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"Although much has been learnt in recent years, the 
physiological functions of the prostaglandins remain 
obscure. Certainly their significance in labour 
can only be a matter of conjecture, their therapeutic 
value, if any, will be determined only after more 
extended study". 
Embrey, M.P. (1969). The Effects of Prostaglandins 
on the Human Pregnant Uterus. The Journal of Obstetrics 
and Gynaecology of the British Commonwealth, Volume 76, 
pp. 783-789. 
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SUMMARY OF CONTRIBUTION TO KNOWLEDGE OF THIS 
INVESTIGATION 
The present investigation was undertaken in order to 
assess the clinical effects of prostaglandins and to evaluate 
their role in present modern day obstetrics. To this end 
pertinent clinical and laboratory studies were carried 
out. This has not been done before in the Republic of 
South Africa. It is considered that the following 
contributions to knowledge have been made: 
1. In comparable patients prostaglandin F 2a and oxytocin 
are e~ually effective in labour induction at term. 
2. Prostaglandin F2a is more effective in labour induction 
where the cervix is unripe and amniotomy is performed. 
3. Amniotomy statistically significantly increases the 
success rate of induction of labour where prostaglandin 
F2a is used as the oxytocic agent. 
4. Amniotomy statistically significantly accelerates labour 
in both prostaglandin F2a and oxytocin induction, using 
labour parameters for comparison which have been devised 
and are described in the text. 
5. Comparable titration schedules of prostaglandin F2a 
and oxytocin have been devised for labour induction. 
6. Prostaglandin F2a is not antidiuretic when used to 
induce patients with classical pre-eclampsia as compared 
with oxytocin. 
7. Prostaglandins are implicated in the acceleratory 
phase of normal labour. 
8. The only statistically significant side effect produced 
by prostaglandin F2a when compared with oxytocin is a 
transient red line in the skin along the area draining 
the site of the intravenous infusion. 
9. Prostaglandin F2a does produce a coordinate form of 
labour if certain precautions are adhered to. 
10. Effacement of the cervix in the latent phase has been 
measured and may be used in order to predict the rate 
of progress in the first stage of labour in primigravidae. 
The results are presented in the text. 
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PART l 
INTRODUCTION AND REVIEW OF THE LITERATURE 
.1. 1 INTRODUCTION 
Folk lore in certain parts of Africa, including 
Liberia, Zambia and in parts of the Congo, suggests that 
prostaglandins have been in use clinically in obstetrics 
for centuries. In these parts it is said that if a 
woman's labour is prolonged her husband is summoned and a 
delicate potion is prepared using an aliquot of his 
seminal fluid. The potion is then administered orally 
and is reported to have accelerated the course of labour. 
From a pharmacological standpoint, however, the 
pharmacodynamic effects of extracts from seminal fluid and 
male accessory organs were discovered by Goldblatt ( 1933 ., 
1935) of St. Thomas's Hospital, London and Von Euler (1934) . 
They independently found that this material contains 
a blood pressure-lowering factor and that it stimulates 
different smooth muscle organs. Von Euler (1936) later 
demonstrated that these effects were due to a lipid-
soluble substance with acidic properties, which he called 
prostaglandin (Von Euler, 1935). He called it by this 
Greek word as he thoughtit originated from the prostate 
gland. He stated that 'the ether and water soluble 
substance, which has the effect of lowering blood 
pressure and stimulating various isolated smooth muscle 
organs is provisionally named prostaglandin'. 
Ironically enough this is a misnomer, for in 1959 
it was shown, by fractionation of ejaculates, that the 
source of prostaglandin was the seminal vesicles and not 
the prostate gland (Eliassen, 1959). 
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1 • 2 HISTORICAL BACKGROUND 
In 1935 M.W. Goldblatt wrote 'the possibility that 
seminal plasma may have functions other than those of 
nutrition of the spermatozoom and of mechanically 
sweeping out the latter from the urethra is suggested 
by recent work of Von Euler (1934) and Goldblatt (1933) '· 
The former worker employed human seminal fluid 
whilst the latter used both the native fluid and extracts 
made with aqueous alcohol and aqueous acetone. Goldblatt 
(1935) showed seminal plasma and extracts to have powerful 
oxytocic activity on the uterus of the virgin guinea-pig 
in a 30cc bath of oxygenated Tyrode solution. He could 
not ascribe a role to this substance in human seminal 
fluid which produced strong vasodilatation and stimulation 
of smooth muscle, but he felt it improbable for it simply 
to be an excretory product without physiological function. 
'The composition of seminal plasma is so peculiar when 
compared with other body fluids and so specially adapted 
to the functions of nutrition and mobilization of the 
sperm cells that the presence of a substance with marked 
pharmacological properties can scarcely be regarded as 
fortuitous'. 
The first reference, however, to the existence of 
these compounds was made by Raphael Kurzrok, Charles 
C. Lieb and Sarah Ratner, from the Departments of 
4 
Biochemistry, Pharmacology and Obstetrics and Gynaecology, 
Columbia University in 1930. In a paper entitled 'The 
Action of Semen on the Human Uterus', Kurzrok had noted 
that when attempting artificial insemination by injecting 
0.5ml of semen into the uterine cavity, it was promptly 
expelled (Kurzrok & Lieb, 1930). This did not occur 
when Ringer's solution was used. Using human uterine 
muscle strips they found that the response of the human 
uterus to semen is variable, causing either relaxation or 
contraction. These workers were primarily interested in 
the relationship to fertility of this uterine response. 
A few years later, on 15th December, 1933, M.W. 
Goldblatt read a paper to the 159th meeting of the 
Biochemical Society in the Medical Lecture Theatre, St. 
Thomas's Hospital Medical School, in which he had 
observed the powerful contraction of the isolated guinea-
pig uterus when an alcohol or acetone extract of human 
seminal fluid was applied to it (Goldblatt, 1933). 
At about the same time, Von Euler of the Karolinska 
Institutet observed independently (1934, 1935) that 
'extracts and secretions from the human prostate gland 
and seminal vesicles, as well as seminal fluid, greatly 
lower the blood pressure after injection into animals 
and even, in small amounts, stimulate the isolated 
intestine and the uterus (Von Euler, 1936). 
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As mentioned before he called this extract from the 
human seminal fluid, prostate and seminal vesicles, 
prostaglandin, and extracts from the seminal vesicles 
alone he called vesiglandin, as he felt it differed 
distinctly from prostaglandin (Von Euler, 1936). 
It must not be forgotten that even prior to the 
work of Kurzrok & Lieb in 1930, biological actions of 
extracts from the accessory genital glands had been 
described several times before (Japelli & Scafa, 1906; 
Thaon, 1907; Camus & Gley, 1907; Gotzl, 1910; Dubois & 
Boulet, 1911, 1919; Battez & Boulet, 1913) but these 
older demonstrations received no great attention, 
probably because the experimental data did not permit of 
definite conclusions as regards the nature and specificity 
of the active constituents. 
Von Euler (1936) went on to describe a technique 
for prostaglandin extraction and purification by 
precipitating inert material with acid, alcohol or 
acetone and then extracting the active principle with 
ether from the acidified water solution. He found 
that the prostaglandin stimulated isolated strips of 
the human uterus, as well as animal uterus. By 
extraction with ether he excluded that this effect was 
due to histamine as Goldblatt had suggested in 1935. 
After extensively studying the biological properties of 
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prostaglandin obtained from human seminal fluid and 
sheep vesicular glands, Von Euler attributed a physio-
logical role to these substances and felt that they 
probably were autonomic regulators for emptying the 
accessory genital glands i.e. when the smooth muscle 
stimulating principle had accumulated sufficiently it 
would act as a stimulus for emptying the glands. 
Early chemical work in elucidating the structure of 
prostaglandins was carried out by Bergstrom (1949) who 
obtained a stable barium prostaglandin preparation. He 
confirmed Von Euler's findings that the biological 
activity was due to a new group of highly active lipid-
soluble unsaturated hydroxy acids. 
In 1959 Eliassen from the Department of Physiology, 
Karolinska Institutet, Stockholm, found that the prosta-
glandin present in seminal fluid in man was secreted 
exclusively from the seminal vesicles. This was shown 
by analysis of various constituents in the different 
fractions of split ejaculates (Eliassen, 1959). 
He also found that prostaglandin may be of 
importance for the motility of the spermatazoa and may 
facilitate sperm migration in the female genital tract. 
Prostaglandin was found to produce, in most cases, an 
7 
increase in tone and activity of various smooth muscle 
organs. This,however, was not the case with the 
isolated human non-pregnant uterus, where it caused a 
decrease in activity and tone. 
At the suggestion of Professor Von Euler in 1947 
Professor Bergstrom started an investigation of the 
purification of a concentrate prepared by I.G. Farben 
from Icelandic sheep glands but only a small amount of 
material was available. The activity was shown to be 
associated with a fraction containing unsaturated hydroxy 
acids, which Bergstrom (1967) felt consisted mainly of 
a mixture of prostaglandins. 
For technical reasons the project was laid aside 
until 1956 when the collection of frozen sheep glands 
was organised in the Northern Hemisphere. Thus it was 
not until the late 1950's that it was realised that 
prostaglandin was not a single substance but a mixture 
of several chemically related substances. This probably 
accounts for the variable results found before. The 
isolation in pure crystalline form from vacuum dried 
sheep prostate glands of the first 2 prostaglandins was 
described by Bergstrom & Sjovall (1960a, 1960b) in the 
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Department of Chemistry, Karolinska Institutet, 
Stockholm, Sweden, in 1960. 
now called PGE 1 and PGF 2a. 
These 2 prostaglandins are 
In 1962 their chemical structure was elucidated 
(Bergstrom, Ryhage, Samuelsson & Sjovall, 1962). 
Analysis of the first few milligrams by ultramicro-
analysis and mass spectrometry proved that these 
substances were c20 compounds possessing a unique 
structure (See Figure 1, page 12). Several related 
prostaglandins have since been isolated from human 
seminal plasma and sheep vesicular glands and their 
chemical structure elucidated. PGE 2 and PGE 3 were 
subsequently isolated from the sheep glands. Mass 
spectrometry and nuclear-magnetic response yielded most 
of the complete structure (Samuelsson, 1963). They were 
identical with PGE 1 , except that they contained 
respectively 1 and 2 additional cis double bonds (See 
Figure 2, page 12). The corresponding PGF2 a and PGF 3a 
were first isolated from sheep and bovine lung tissue 
(Samuelsson, 1964). 
The structure of the 6 primary prostaglandins has 
been demonstrated in a number of different tissues. 
They occur in low concentrations, however, compared to 
the human seminal fluid which is the richest known 
source. Human seminal fluid contains 13 different 
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prostaglandins. These are the 5 initially recognised 
prostaglandins mentioned above: PGE 1 , PGE 2 , PGF 1a and 
PGF2a (Bergstrom & Samuelsson, 1962; Sam
uelsson, 1963) 
and the recently isolated additional 8 compounds: PGA1 , 
PGA2 , PGB, PGB 2 , 19-hydroxy-PGA, 19-hydrox
y-PGA2 , 
19-hydroxy-PGB and 19-hydroxy-PGB2 (Hamberg & Samuelsson, 
1966). 
The elucidation of the structure of the 6 primary 
prostaglandins led to the speculation that the essential 
fatty acids might be the natural precursors for the 
prostaglandins. That this was the case was proven by 
Dr. Van Dorp's group in the Unilever research laboratories 
in Holland, by Bergstrom's group in Sweden and by a group 
at the Upjohn Company in the U.S.A. This discovery in 
its turn led to the biosynthetic production of the 
primary prostaglandin compounds. Following this the 
total chemical synthesis by several methods was brought 
to practical use during the late 60's. 
A new field of active analogues of prostaglandins is 
appearing and this should develop rapidly. At the time 
of the preparation of this thesis, however, only the 
primary prostaglandin F2a was available to the author. 
The early work on the physiological properties of 
prostaglandin was done with extracts of sheep vesicular 
glands or human seminal plasma as mentioned above on 
page 7 . It was mainly limited to the cardiovascular 
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system and to the reactions of smooth muscles in the 
intestines and in the female reproductive tract. 
The physiological properties of the many prosta-
glandin compounds that have been isolated subsequently 
and the achievement of biosynthetic production and 
total chemical synthesis of the prostaglandins has led 
to the study of prostaglandins in many laboratories, so 
that the publications are exhaustive. As this thesis 
is concerned with the role of prostaglandins in re-
production a review of the wide variety of actions of 
these substances is outside its scope. A good review 
of the actions of prostaglandins has been prepared by 
Horton (1969). Even since that review newer and more 
varied physiological roles have been attributed to the 
prostaglandins and these were presented at an Inter-
national Conference on Prostaglandins in Vienna in 
September, 1972 (Bergstrom, 1973). 
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1. 3 SUMMARY ON NOMENCLATURE 
The cyclopentane fatty acid, prostanoic acid, forms 





The group of 'primary prostaglandins' consists of 
6 prostaglandins which are formed b y conversion of 
8, 11, 14-Eicosatrienoic acid (homo -'ii - linolenic acid) : 
5, 8, 11, 14-Eicosatetraenoic acid 
(arachidonic acid): PGE 2 and PGF2a ; and 5
, 8, 11, 14 
17-Eicosapentaenoic acid: PGE 3 and PGF 3a (See
 Figure 2). 
FIGURE 2 
BIOCONVERSION TO 'PRIMARY PROSTAGLANDINS' 
~ - ~· 
8, 11,14-Eocosalri • no,c ac id ~ 'c)H 
(Homo-1-tinol• nic acid ) PGE, PGF,., 
~ - ~-·~' 
Hb 'o H H6 'oH 5,8, ll 14 - Eicosat• tra•noic acid 
I Arnchidonic acid) 
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The chemical relations between PGE, PGF, PGA and 
PGB compounds are given in Figure 3. 
FIGURE 3 










The letters E and Fin PGE and PGF refer to an early 
finding that PGE and PGF compounds could be partly 
separated by extraction with ether from phosphate buffer. 
The PGE compounds mainly appeared in the ether phase, 
whereas the PGF compounds mainly stayed in the phosphate 
(fosfat, in Swedish) buffer. The letters A and Bin 
PGA and PGB refer to the formation of these derivatives 
from PGE compounds by acid and base treatment respective-
ly (Hamberg, 1973) . 
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Prostaglandin F2a (PGF2a) was used in th
is study. 
It is a c20 prostaglandin and its systematic name 
is 9, 
11, 15L - Trihydroxyprosta - 5 cis, 13 trans - dienoic 
acid. It was supplied by the Upjohn Company in ampoules 
containing aqueous solutions of Smg/ml PGF2a equivalents 
as the THAM salt. 
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1. 4 'PROST"AGL'ANDINS IN PARTURITION 
Effects of Pros'taglandins in Seminal Plasma o·n the Human 
Uterus: 
The 3 PGE compounds (PGE 1 , PGE 2 and PGE 3 ) 
all decrease 
tonus, frequency and amplitude of the spontaneous motility 
of human non-pregnant myometrium in vitro (Bygdeman, 1967). 
The effect of the 2 PGF compounds (PGF 1a and PGF2a) 
differs 
and causes stimulation. Their effect is characterised by 
an increase in tonus, amplitude and frequency. 
Eglington, Pickles and their colleagues, however, 
(Eglington et al, 1963; Pickles & Hall, 1963; Pickles et 
al, 1965) found that PGF 2a invariably incr
eased the 
contractions of human non-pregnant myometrium, while 
PGE 2 gave a variety o
f effects, varying from mild 
stimulation to complete inhibition. 
Pregnant myometrium reacted differently from non-
pregnant myometrium to the prostaglandin compounds. 
Small doses of prostaglandin E1 (0.01 - 0.03 µg/m
l bath 
fluid) in some cases stimulated motility, the effect 
on tonus being most pronounced. An increase dose 
(0.03 - 0.1 µg/ml) gave the normal inhibition. The PGF 
compounds stimulated the motility in a similar way as 
with non-pregnant myometrium (Bygdeman, 1964). In 1968 
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Embrey & Morrison studying human pregnant myometrium in 
vitro found that while lower segment myometrium was 
relatively inactive, well marked effects were observed 
with upper segment myometrium (Embrey & Morrison, 1968). 
Not only did the F prostaglandins (PGF 1a and PGF2 a) 
exhibit stimulatory effects but, for the first time, it 
was shown that, contrary to expectation, E group 
prostaglandins (PGE 1 , PGE 2 ) also produced spasmogenic 
effects on pregnant myometrium. 
Embrey (1969) then confirmed these results in a 
study on the intact uterus in pregnancy. Both the E 
and F prostaglandins stimulated myometrial contractility. 
In late pregnancy both PGE 2 and PGF 2a produced significant 
increases in the amplitude and frequency of contractions 
without, in the dosage used, causing appreciable hyper-
tonus or undesirable side effects. The findings pre-
viously reported in vitro were thus corroborated. 
Embrey (1969) found the striking oxytocic effects of the 
E prostaglandin on the uterus in pregnancy of particular 
interest - because it differs from its reported inhibitory 
action in the non-pregnant state, emphasising that the 
effect of a pharmacological agent is influenced by the 
physiological state of the organ. The sensitivity of 
the human myometrium to the prostaglandins not only 
varies as to whether it is pregnant or not but also with 
the stage of the menstrual cycle. 
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The inhibitory effect of PGE is most pronounced 
around ovulation time and less during other phases of 
the menstrual cycle (Bygdeman, 1964). 
Because of the action which prostaglandins seem to 
exert on the human myometrium, a great interest in the 
relationship of these compounds to labour was aroused. 
Amniotic fluid is rich in prostaglandins (Karim, 
1966). Prostaglandins Fla and F2a are only found in 
liquor during labour. There is an increased amount of 
PGE2 in the li
quor during labour as over term. Prosta-
glandins E2 and F2a are found in the
 maternal circulation 
only during labour (Karim & Devlin, 1967; Karim, 1968a). 
Gillespie et al (1972) investigated the possibility that 
prostaglandins cause the release of oxytocin from the 
maternal pituitary in a manner which corresponds closely 
to that found in spontaneous late first stage labour. 
Brummer (1971) demonstrated that after exposure to 
the E prostaglandin, human pregnant myometrial strips in 
vitro show a greater contractile response to a given dose 
of oxytocin than before the exposure to prostaglandin. 
This phenomenon is termed enhancement. Gillespie (1972) 
confirmed this phenomenon in vivo and in addition 
demonstrated a 'potentiation' of effects if prostaglandin 
E or Fis administered simultaneously with oxytocin. 
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Labour was successfully induced in 29 out of 35 
women at or near term with a continuous infusion of PGF2a 
by Karim et al (1969b). 
Since then there have been many reports of the 
successful induction of labour with prostaglandins F2a' 
E1 and E2 (Karim et al, 1970; Beazley et al, 1970; 
Embrey, 1970). Vakhariya & Sherman (1972) felt that 
PGF2a is as effective as oxytocin for the induction of 
labour in multiparous patients at term. Karim (1971) 
reported 96%, 67% and 56% success rates in 100 inductions 
each with PGE 2 , PGF 2a and oxytocin respectively. Embrey 
(1969, 1970) found the effects of PGE 2 and PGF2 a to be 
8Ualitatively similar, but dose for dose the stimulating 
properties of PGE2 were greater than those of PGF2a in 
late and early pregnancy . 
Beazley & Gillespie (1971) induced labour in 150 
patients each with PGE 2 and oxytocin, with a success rate 
of 73% for both drugs. Roberts & Turnbull (1971) 
reported 4 cases of uterine hypertonus in 18 women with 
labour induced at term with PGE 2 . Anderson et al (1971) 
also noticed mild hypertonus in 2 patients, 1 with PGF2a 
and 1 with PGE2 induction. Vakhariya & Sherman (1972) 
observed hypertonus in 7 cases. Besides hypertonus other 
side effects have been reported - Vakhariya & Sherman 
(1972) reported a generalised and a localised rash in 2 
cases. Conflicting results have therefore been reported 
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both as regards success rates, which were not always 
clearly defined, and as regards side effects. 
It has therefore not been established whether 
prostaglandins are more or less efficient, or safer than 
oxytocin for the induction of labour at term. The 
reasons for this are quite clear, namely: 
1. A strictly supervised study has not been performed. 
2. Comparable doses were not established prior to 
starting the studies. 
3. Patients were not matched for factors known to affect 
the response to induction of labour. 
As these factors have received inadequate scientific 
consideration it was considered pertinent to examine them 
all together in a carefully planned study. This was 
thought to be particularly important in South Africa 
which has no abortion law, as most studies on prosta-
glandins are now on first and second trimester terminations 
and the place of prostaglandins in induction of labour at 
or near term has remained unsettled. 
This thesis was commenced in January, 1971, and 




OBJECTIVES OF THE PRESENT STUDY 
A strictly controlled investigation was therefore 
undertaken in order to clarify the efficacy of 
prostaglandin F 2a in labour induction in comparison to 
oxytocin, including a study of side effects, using 
statistically matched patients and comparable dosage 
schedules of the 2 drugs. Further, an attempt was made 
to determine a possible role for prostaglandin F2a in 
spontaneous labour. 
To this end the following studies were carried out: 
1. A study to determine comparable dosage schedules of 
prostaglandin F2a and oxytocin for labour induction so 
that a valid comparison could be made. 
2. A study comparing the success of labour induction in 
matched patients receiving oxytocin or prostaglandin 
F 2a without amniotomy. 
3. A study comparing the success of labour induction in 
matched patients receiving oxytocin or prostaglandin 
21 
F2a with amniotomy being performed at the time of induction. 
4. To determine if the advantages claimed for prostaglandins 
in induction with an unripe cervix are real or spurious 
(Karim et al, 1970). 
5. To assess the quality of the labour produced by the 
2 drugs. 
6. A study to determine the anti-diuretic effects of the 
2 drugs in the induction of patients suffering from 
classical pre-eclampsia, the lack of an anti-diuretic 
effect being a supposed advantage of the prostaglandins 
(Roberts et al, 1970). 
7. A study comparing the effects of a beta-adrenergic 
agent on labour induced alternatively with prostaglandin 
F2a and oxytocin. 
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PART 3 
PATIENTS AND METHODS 
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3.1 PATIENTS 
The principal aims of this study required a 
detailed clinical history and examination and the 
collection of material from varying groups of women 
in order to match precisely the two treatment groups. 
To this end each patient was assessed personally. 
The study comprised in-patients and out-patients 
of the Obstetric Department of Groote Schuur Hospital, 
Cape Town, who required induction of labour on 
obstetrical grounds. 
The effect of ethnic differences on the response 
to induction of labour is unknown. The ethnic 
distribution of the patients in the study is as follows: 
TABLE 1 
THE ETHNIC DISTRIBUTION OF PATIENTS STUDIED 
Race No. of Patients 
Asian 6 
Bantu 9 
Cape Coloured 68 
(Mulatto) 
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The number of patients who were studied in this 
thesis is s uch as to render it impractical to include 
individual case reports. However numerous factors are 
known to affect the response to induction of labour and 
these are considered below in Table 2. 
TABLE 2 
FACTORS AFFECTING THE RESPONSE TO INDUCTION 






Urinary tract infection 
Best estimate of gestational age 





The females in the study ranged in age from 15 to 
30 years. Embrey & Anselmo (1962) found no significance 
attached to age in determining the latent period in 
labour induction. 
HEIGHT 
All patients in the study were of average height, 
i.e. ranging from 150 to 175 cm. Patients of short 
stature had a clinical and an X-ray pelvimetry, using A-P 
and lateral views, in order to exclude cephalo-pelvic 
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disproportion. If this was found they were excluded from 
the trial. 
PRE-DELIVERY WEIGHT 
The patients ranged in weight from 45 to 100 kg. 
+ 
The next Table (Table 3) shows the mean the 
standard deviation, for the factors age, height and 
pre-delivery weight of the patients in each group 
discussed in this thesis. There are no differences 
between the oxytocin and prostaglandin groups for these 
factors. 
TABLE 3 27 
AGE, HEIGHT AND PRE-DELIVERY WEIGHT 
OF THE PATIENTS 
Oxytocin Prostaglandin 
Age Height Weight Age Height Weight 
(Yrs) (Cm) (Kg) (Yrs) (Cm) (Kg) 
Number 43 43 43 40 40 40 
Mean 21.9 155.8 70.1 21.7 157.2 65.9 
S.D. 4.9 5.4 12.5 4.0 6.0 9.9 
P> 0.05 in all factors as measured by Yates's correction 
of chi2 
PARITY 
Only primigravidae were selected to avoid diluting the 
results with multipara, in whom there is a very low incidence 
of prolonged labour (O'Driscoll et al, 1969). 
DRUG INGESTION 
All sedative drugs were discontinued 12 hours prior 
to the induction of labour. 
URINARY TRACT INFECTION 
No patient had a urinary tract infection at the time of 
induction of labour. 
BEST ESTIMATE OF GESTATIONAL AGE 
The gestational ages ranged from 36 to 43 weeks as 
confirmed post-natally by paediatric examination. The 
mean gestational age for both groups was 40 weeks. 
STATION OF THE PRESENTING PART 
Embrey & Anselmo (1962) feel that the degree of engage-
ment of the presenting part or 'head station' is important 
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to the successful induction of labour and is important in 
determining the length of the latent period in primigravidae. 
This was therefore very carefully determined by the author 
in every case at the time of induction of labour. 
Engagement of the fetal head was determined both by the 
reversed Lovsett's manoevre and by the techni'que of Fifths 
first described by Crichton (Philpott et al, 1972). He 
defined the level of the head in relation to the brim of 
the pelvis as the number of fifths still above the brim 
of the pelvis (See Figure 4 below). 
FIGURE 4 
THE 'FIFTHS' TECHNIQUE OF ASSESSING ENGAGEMENT 
OF THE FETAL HEAD 
COMPLETELY SINCIPUT ++ SINCIPUT ++ SINCIPUT + 
ABOVE OCCIPUT ++ OCCIPUT + OCCIPUT 
JUST FELT 
FLOATING FIXING NOT NEARLY ENGAGED DEEPLY 
ENGAGED ENGAGED ENGAGED 
On vaginal examination the head was classified as 
being 1, 2 or 3 cm above or below the ischial spines. 
If the presenting part was level with the ischial spines 
a zero was recorded (See Table 4 below). There was 
no statistical difference between the two groups (P>0.05). 
TABLE 4 
THE HEAD STATION IN EACH GROUP (CLASSIFIED 
ACCORDING TO THE STATE OF THE CERVIX) 
Unripe Ripe 
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Oxytocin Prostaglandin Oxytocin Prostaglandin 
- 3cm 16 17 9 5 
- 2cm 10 3 3 7 
- 1 and 
0 cm 1 4 4 4 
THE STATE OF THE CERVIX 
Garrett (1960) feels that the state of the cervix is 
the only sign of practical importance in the prediction 
of the outcome of surgical induction of labour and Embrey 
& Anselmo (1962) showed the ripeness of the cervix to be 
the most influential clinical feature in labour induction 
using oxytocin. The author felt, however, that in 
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addition to dilatation the length of the primigravid cervix 
is a major factor in considering the latent period after 
induction of labour in primigravidae. There is no guide 
on this point in the literature. The length of the 
primigravid cervix was regarded arbitrarily as 3 cm at 
the onset of labour. It was measured by placing the 
middle finger at the internal os and then marking off 
the length of the distal part of the cervix on this 
finger. This length was then measured with a rule and 
expressed as a percentage of 3 cm. 
illustrated in the diagram below: 
This technique is 
Table 5 below shows the degree of effacement in the 
oxytocin and prostaglandin groups, classified according 
to the state of the cervix. There is no statistical 
difference between the 2 groups (P > 0.05). 
TABLE 5 
CERVICAL EFFACEMENT IN EACH GROUP 
(CLASSIFIED ACCORDING TO THE STATE OF THE CERVIX) 
Unripe Ripe 
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Oxytocin Prostaglandin Oxytocin Prost.aglandin 
0 -30% 20 15 2 4 
40-50% 4 7 4 2 
60-70% 3 2 5 2 
80+ % 0 0 5 8 
In assessing the dilatation of the cervix, no forceful 
attempt was made to introduce the finger into or through 
the cervical canal as it was felt that this might cause 
discomfort to the patient and might prejudice the onset or 
the progress of labour. All measurements were made 
against a standard plastic scale kept at the bedside (See 
photograph below). 
Table 6 shows the mean~ S.D. of the cervical 
dilatation of each group, classified according to the 
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state of the cervix. There is no statistical difference 
between the 2 groups (P> 0.05). 
TABLE 6 
INITIAL DILATATION OF THE CERVIX IN OXYTOCIN 
AND PROSTAGLANDIN GROUPS 
(CLASSIFIED ACCORDING TO THE STATE OF THE CERVIX) 
Unripe Ripe 
Oxytocin Prostaglandin Oxytocin Prostaglandin 
F2a F2a 
Number 27 24 16 16 
Mean 0,93 cm 1,04 cm 2,08 cm 2,50 cm 
S.D. 0,68 0,58 0,76 0,67 
Friedman (1967) has shown that the error with digital 
examination, as opposed to a cervimeter, is insignificant, 
and that frequent digital examination is a much more 
expedient, albeit less critical, means of establishing the 
same end. 
Table 7 (a) below records the consistency in each 
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group. The consistency of the cervix was recorded as firm, 
medium or soft. The position of the cervix was classified 
as being posterior, mid-line or anterior and is shown in 
Table 7 (b) below. There is no statistical difference 
(P>0.05) between the oxytocin and prostaglandin groups for 
the factors consistency and position. Variations in 
interpretation of the cervical state were avoided by having 
1 person assess the cervix (Anderson, 1965) and all the 





TABLE 7 (a) 
CONSISTENCY OF THE CERVIX IN EACH GROUP 
CLASSIFIED ACCORDING TO THE STATE OF THE CERVIX 
Unripe Ripe 
Oxytocin Prostaglandin Oxytocin Prostaglandin 
F2a F2a 
4 3 0 0 
6 5 1 4 
17 16 15 12 
TABLE 7 (b) 
CERVICAL POSITION IN EACH GROUP 
CLASSIFIED ACCORDING TO THE STATE OF THE CERVIX 
Unripe Ripe 
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Oxytocin Prostaglandin Oxytocin Prostaglandin 
F2a F2a 
Posterior 16 12 4 3 
Mid-line 10 10 8 11 
Anterior l 2 4 2 
The cervix was assessed prior to induction and then 
every 2 hours thereafter. Strict asepsis was observed 
during every vaginal examination. Changes in dilatation 
and effacement were recorded against a time scale and 
'cervicograms' and 'effacement~grams' are shown below. 
These were kept on all 83 patients studied in this thesis. 
CERVICOGR AM/ EFFACEMENTGRAM 
NAME of PATIENT __________ _ 















TIME in HOURS 
UTERINE IRRITABILITY 
Uterine irritability was assessed clinically by 
means of the contractile response to palpation. In 
addition the number of painless contractions over a ten 
minute period (as recorded on the cardiotocograph) was 
counted for each case. 
the two groups. 
No difference was found between 
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PAST MEDICAL AND SURGTCAL HISTORY 
Patients with a history of cardio-vascular disease 
or on maintenance drug therapy prior to their pregnancy 
were excluded from the study. Further, any patient 
who had had any surgical procedure which might conceiv-
ably have influenced the course or outcome of labour was 
excluded . 
3 • 2 · METHODS 
3.2.1 GENERAL 
All the patients studied had the same history taken 
and the same examinations and investigations performed 
at each visit. Accordingly a set protocol or trial 
form designed by the Upjohn Company, Kalamazoo, Michigan 
was used. During the study,factors were encountered 
which necessitated revision of the form. The altera-
tions are cross-hatched in Appendix A. These are 
mainly as a result of using primigravidae only. The 
cervical changes are analysed in detail later. 
After completion of the study all data were trans-
ferred on to Univac 1106 computer punch cards for 
subsequent analysis and statistical evaluation through 
a Univac 1106 computer. 
Appendix B. 
The punch card code is seen in 
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3.2.2 CONS'ENT 
Provided all the criteria demanded by the study had 
been satisfied the patient was interviewed and the 
project fully explained to her. Great care was taken 
to ensure that the patient understood that the proposed 
research entailed investigations and procedures which 
were of a non-essential nature and were being done for 
research purposes and carried slight, but definite risks 
to both the mother and the fetus, over and above the 
normal risk of labour. If, having had the proposed 
study explained, any patient showed signs of hesitancy 
or fear, she was excluded from the group . If there 
were any objections from the nusband, the patient was 
excluded. In addition, there must have been no history 
of involuntary infertility of more than 1 year's duration. 
If the husband was agreeable that his wife participate in 
the research project, written consent was obtained. 
3.2.3 ANTENATAL CARE 
All the patients had attended antenatal clinics and 
were managed at these attendances according to the rules 
of the Department of Obstetrics and Gynaecology of the 
University of Cape Town. Each patient was seen at 2 
weekly intervals up to the 36th week of pregnancy and 
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at weekly intervals thereafter. If any pregnancy 
complication was noted the patients were admitted into 
the wards. At each visit the patients were weighed, blood 
pressure recordings made, the height of the fundus 
palpated and the fetal heart auscultated. Urine analysis 
for the presence of proteinuria and glycosuria was under-
taken at each visit. All information was recorded on the 
patient's antenatal notes. 
3.2.4. INDICATIONS FOR INDUCTION OF LABOUR 
Only patients requiring induction on obstetric 
grounds were selected. The indications are listed below: 
TABLE 8 
INDICATIONS FOR THE INDUCTION OF LABOUR 
Drug Used 
Indication 
PGF 2a Oxytocin 
Hypertension and 
weight gain 3 3 
Hypertension and 
proteinuria 4 4 
Hypertension alone 16 18 
Postmaturity ( > 42) 13 14 
Placental insufficiency 1 2 
Diabetes 2 2 
Term with Clomiphene 
induced pregnancy 1 
Total 40 43 
The ultimate number of patients completely studied 
was 83, divided into 2 major sub-groups. The first 
group comprised 43 patients in whom amniotomy was not 
performed at the time of induction of labour. The 
second group of 40 patients had the membranes ruptured 
at the time of induction of labour. 
3.2.5 'PRE-TNDUCTION MANAGEMENT 
All patients requiring induction of Jabour were 
initially admitted into the antenatal ward. During a 
personal assessment by the author a history was taken and 
the patient examined to determine the clinical condition 
present. The data obtained were recorded on the proto-
col form (See Appendix A). When performing abdominal 
examination the traditional relationship of the uterine 
fundus to abdominal landmarks at different gestational 
levels throughout pregnancy was used (The Queen Charlotte's 
Textbook of Obstetrics, 1970). When patients were un-
certain of the date of their last normal menstrual period 
a single X-ray film of the abdomen was taken on one 
occasion during the last 10 weeks of pregnancy . As it 
would appear from the literature (Russell, 1969) that the 
time that this investigation yields most information is 
after the 36th week of pregnancy an attempt was made to 
X-ray the patients after this stage of their pregnancies. 
39 
Special attention was given to the assessment of 
the cervix, as described above on page 30. 
Antenatal management in the wards was otherwise as 
is routine for the Department of Obstetrics and Gynae-
cology of the University of Cape Town, except where the 
patient's clinical condition is indicated. All drug 
therapy was discontinued and buccal oxytocicswere 
forbidden. 
SPECIAL INVES'TI'GATIONS 
Maternal blood was collected from the antecubital 
vein immediately before, during and 12 hours after labour. 
The blood urea was measured and a haematological analysis 
made by standard methods in the Departments of Chemical 
Pathology and Haematology of the University of Cape Town. 
METHOD OP UREA ESTIMATION 
Blood urea was analysed using a Technicon Auto-
Analyzer. The method employed was the diacetyl monoxime 
method using thiosemicarbazide to enhance the colour 
formation (Technicon Method N-lb, Technicon Methods 
Manual). 
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METHOD OF HAEMATOLOGICAL 'ANALYS'IS 
Haemoglobin, Red Cell Count, Mean Red Cell Volume, 
Mean Cell Haemoglobin, Haematocrit, Mean Cell Haemo-
globin Concentration and Total White Cell Count were 
performed using a Coulter Counter, Models. 
Platelet counts were performed manually and using 
a Coulter Counter Model Fn. 
3.2.6 TECHNIQUE OF INDUCTION OF LABOUR 
On the morning of induction the patient was trans-
ferred into the labour ward. The patients were starved 
and an intravenous infusion was commenced, using a 
Baxter R41 infusion set (10 drops/ml) into a large arm 
vein. The drip rate was regulated by an Ivac constant 
infusion pump. · 
As it had been claimed that prostaglandins are more 
effective in labour induction when the cervix is unripe 
(Karim et al, 1970), it was initially decided to test 
these cases without rupturing the membranes at the onset 
of the infusion, as it may be difficult to rupture mem-
branes with an unripe cervix. This was followed in the 
first 43 patients. The technique of rupturing the mem-
branes carried out in the remaining 40 patients in this 
study was as described below: 
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The patient was placed in the dorsal position and 
following an aseptic technique which involved the surgeon 
'scrubbing up' and the patient being swabbed and draped 
with sterile towels, a vaginal examination was performed. 
The index finger was inserted through the cervix and the 
membranes swept to as high a level as possible. A 
forewater rupture was performed using Kocher's forceps 
and as much liquor as possible was allowed to drain. At 
the completion of this procedure the fetal heart was 
closely auscultated. Either prostaglandin F2a or 
oxytocin was then added to the infusion bottle, depending 
on whether the patient's case record number ended in an 
odd or even digit. These agents were administered on 
a titration basis according to the schedules outlined on 
page 49 . 
OBSERVAT'IONS' DURING LABOUR 
All patients were attended by a 'special' nurse 
and half-hourly recordings of the maternal pulse rate 
and blood pressure were made . 
Uterine contractions and fetal heart rate recordings 
were monitored throughout labour with a Hewlett Packard 
cardiotocograph 8020A. Baseline recordings were 
obtained for at least 15 minutes before the start of the 
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infusion. This was calculated as seconds/10 minutes of 
contractions and no statistical difference was found 
between the 2 groups and in neither were any patients in 
labour. The uterine activity could not be quantitated 
because external tocography of the uterus was used, to 
avoid any possibility of mechanical stimulation of the 
uterus (Embrey, 1969). 
The times of alteration in the infusion rate were 
recorded, ensuring knowlege of the total quantity of 
each agent used . 
The presence of any maternal cardiovascular or 
gastro-intestinal side effects was noted. Strict fluid 
balance charts were kept, and the patients were catheter-
ised at the endpoint of the trial to ensure an accurate 
estimation of their urinary output. 
Fetal well being was assessed by Apgar scores taken 
at 1 and 5 minutes. 
43 
3.2.7 'CRITERIA OF A SUCCESSFUL INDUCTION 
Induction of labour was considered successful when 
5cm dilatation of the cervix had been achieved, or 
delivery had occurred within 12 hours of the start of 
the infusion. Five cm was selected arbitrarily as the 
endpoint as a primigravid patient is unquestionably in 
established labour at this dilatation and labour can 
therefore be regarded as successfully induced. 
For further comparison of the 2 drugs to be made, 
certain fixed points in labour were selected by which 
this could be done. The first point was where initial 
contractions (I.C.) occurred (Scher et al, 1972). This 
was the first appearance of stimulated uterine activity 
on the cardiotocograph paper. The next point was where 
regular contractions became painful to the patient. 
Anderson (1965) took this point of painful contractions 
as the onset of labour. This was known as the point of 
adequate contractions (A.C.). The endpoint of the trial 
was the next parameter used for comparison and this was 
the point at which the cervix reached 5cm dilatation. 
3 . 2. 8 . 'CALCULATION OF TITRATION SCHEDULES FOR PROST.AGLANDIN 
F . . AND OXYTOCIN 
-2 a~~~~~~~ 
It is fruitless to argue which is the stronger of 2 
drugs. The clinician wants safe delivery and the effects 
of equivalent drugs must therefore be those which provide 
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this . It was felt that unless comparable dosage 
schedules of the 2 drugs were used no conclusion would be 
able to be drawn about their relative effectiveness. 
Dewhurst (1972) feels this comparability to be a major 
point. The author therefore felt it would be important 
to choose a good model using in-patient control to estab-
lish comparable drug dosages. No comparable dosage 
schedules for prostaglandin F 2a and oxytocin were avail-
able in the medical literature and a study was undertaken 
to derive these. This study is described below. 
Patients 
Six primigravid patients who required induction of 
labour on obstetric grounds were selected. All gave 
their informed consent once the procedure had been 
described to them in detail. All the patients were at 
term and only those who were certain of the date of their 
last menstrual period were selected. 
Abdominal palpation recorded a cephalic presentation 
in all the cases. On vaginal examination the cervices 
were effaced and less than 2cm dilated. 
Method 
An anteriorly situated placenta was excluded clini-
cally, and b y ultrasound where uncertainty existed, and 
the lie and position of the fetus determined. The 
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abdominal wall was infiltrated with a local anaesthetic 
agent (1% Lignocaine Hydrochloride - Propan Pharma-
ceuticals) . A surgically aseptic technique was observed 
throughout. The site for puncture was selected as the 
area between the fetal chin and thorax. A Tuohy needle 
was introduced into the amniotic cavity and the trochar 
was withdrawn. An epidural cannula ('PORTEX' with 
needle guard Ref. 100/380/010 Length 90cm) was inserted 
into the amniotic cavity. It was then filled with 
normal saline into which~ gm of Ampicillin 
('Penbritin', Beecham) had been instilled. The catheter 
was then attached to a Hewlett Packard pressure transducer, 
number 1280B, used in conjunction with a Hewlett Packard 
transducer, number 1513713, connected to a Hewlett 
Packard cardiotocograph 8020A. 
Maternal and fetal heart rates were recorded 
continuously phonocardiographically as previously 
described on page 42. 
Oxytocin was then administered intravenously at a 
rate sufficient to produce uterine contractions compat-
ible with early established labour i.e. contractions 
causing a rise of intra-uterine pressure of about 50mm 
mercury above resting pressure every 2 to 3 minutes, with 
a uterine activity of 150 Alexandria units (El-Sahwi et 
al, 1967). The oxytocin infusion was stopped once this 
stage had been reached. 
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PHOTOGRAPH SHOWING TECHNIQUE 
OF DIRECT INTRA-AMNIOTIC PRESSURE RECORDING 
When the uterine activity had returned to the original 
level the first drug was discontinued and prostaglandin F 2a 
was substituted. The whole procedure was then repeated. 
At the conclusion of the experiment the membranes were 
ruptured and labour was allowed to continue. All patients 
were delivered vaginally and all neonates were in good 
biological condition. 
Results 
Table 9 shows the respective dosages of oxytocin and 
prostaglandin F 2a required to produce a similar amount of 










DETAILS OF DRUG DOSAGES AND UTERINE ACTIVITIES 
IN EACH CASE 
Oxytocin Prostaglandin F 2a 
Uterine *Dose Uterine *Dose 
activity (m-u/min) activity (µg/min) 
200 4 224 24 
227 4 251 8 
251 8 230 16 
196 4 184 16 
234 4 220 16 
250 4 260 8 
226 4 2/3 228 14 2/3 
*Alexandria Units (El-Sahwi et al, 1967) 
It can be seen that the ratio of prostaglandin F 2a to 
oxytocin is 3.14:1 when comparing potency. There were 
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no maternal side effects. As a result of this study the 
following titration schedules were calculated: 
49 
OXYTOCIN DOSAGE SCHEME 
Drip Rate 
Oxytocin Dose 15 drops/min 30 drops/min 
4 iu in 1 L 5% D/W 4 8 
16 iu in 1 L 5% D/W 16 32 
64 iu in 1 L 5% D/W 64 128 m-u/min 
20 minute increments 
PROSTAGLANDIN F2a DOSAGE SCHEME 
Prostaglandin F2a Rate 




1 drop= 1 µg 
30 minute increments 
The oxytocin infusion was started at 15 drops/minute, 
the rate being doubled every 20 minutes until the 
contractions were optimal, as recorded on the cardiotocograph. 
It can be seen that if the maximum dose of each drug 
is attained the ratio of oxytocin to prostaglandin is 3.2:1. 
The prostaglandin schedule takes longer to reach this 
maximum dose because of the danger of hypertonus. 
HYPERTONUS ENCOUNTERED WITH THE PROSTAGLANDIN F 2a 
INFUSTON · SCHEME 
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Initially only a 20 minute interval was allowed 
between increasing dosage of the drug, but deflection of 
the uterine pressure recordings from the base line occurred, 
unrelated to interfering factors such as maternal or fetal 
movement. This indicated hypertonus. Intra-uterine 
pressure was then recorded directly intra-amniotically by 
the method described on page 46 in 6 patients who were not 
included in the trial. From Figure 5 the hypertonus 
which occurs on increasing the prostaglandin at 20 minute 
intervals can be seen. Figure 6 shows the lack of 
hypertonus when the interval between doses is increased 
to 30 minutes, even though it can be seen that the initial 
activity was greater in Figure 5. 
FIGURE 5 
TWENTY MINUTE INCREMENTS 
OF PROSTAGLANDIN F 2
a 
20 MINUTE INCREMENTS of PG F2oC 
mmHg 
PG F2oe 20 nigms 
I calibration 
t t 
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Once these comparable dosage schemes for the two 
drugs had been calculated, and the initial difficulty 
which was encountered with the hypertonus using 
prostaglandin F 2a had been overcome, the schemes were 
used throughout this thesis. 
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3.2.9 STATISTICAL ANALYSIS (APPENDIX B) 
All data were analysed through a Univac computer 
with the assistance of a computer programmer and 
statistician (See Acknowledgments). The statistical 
tests applied were basically the student t distribution 
for continuous measurements (eg. weight, height, blood 
pressure) and the chi 2 distribution test for clinical 
features (eg. diarrhoea, venous erythema, vomiting). 
Yates's correction for small sample size was applied. 
Where expected frequencies were less than 5, the exact 
test for fourfold tables was used. 
RESULTS 
In a1i 43 oxytocin inductions are compared with 40 
patients where prostaglandin F 2a was used. Rupture of 
the membranes was performed at the start of the infusion 
in half the cases. The author would again like to 
emphasise that a single person did all the cervical 
assessments to avoid variation in interpretation and the 
cases were 'specialled' by 1 trained research assistant 





4.1 OVERALL SUCCESS RATE FOR EACH GROUP 
By the criteria of success described on page 44 
30 out of 43 oxytocin inductions, or 69%, and 33 out of 
40 prostaglandin F2a inductions, or 82%, succeeded. 
(See Table 12 below). 
TABLE 12 
OVERALL INDUCTION SUCCESS' RATES 











Although the prostaglandin group had a numerically 
better success rate this is not at a statistical level. 
4 • 2 INFLUENCE OF THE STATE OF THE' CERVTX ON THE OUTCOME 
OF THE INDUCTION BY THE 2 AGENTS 
It can be seen from the table below that a ripe 
cervix has a favourable response on labour outcome 
whether prostaglandin F2a or oxytocin is used for the 
induction. This work supports the findings of other 
workers (Embrey, 1969; Garrett, 1960). 
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TABLE 13 
'SUCCESS RATE OF LABOUR INDUCT ION 
RELATED TO THE STATE OF THE CERVIX 





Oxytocin Ripe 15 12 
Unripe 28 18 
Prostaglandin F2a Ripe 16 15 
Unripe 24 18 
4 • 3 THE INFLUENCE OF 'RUPTURE OF THE MEMBRANES ON LABOUR 
INDUCED BY PROST'AGLANDIN F2a AND OXYTOCIN 
As the trial had been carefully controlled and the 
cases had been compared for the factors affecting 
inducibility the remaining variable was rupture of the 
membranes. 
The author ruptured the membranes at the time of 
the onset of the infusion using a standard technique. 
This involved sweeping the membranes off the lower uterine 
segment and then rupturing the forewaters with a Kocher's 
forceps. Table 14 below shows the effect of rupture of 




THE EFFECT OF AMNIOTOMY 
ON PROSTAGLANDTN F2a INDUCED LABOUR 












The failure rate when arnniotomy is performed is 
statistically significantly reduced (p < 0.05) . 
From Table 15 the effect of arnniotomy on labour 
induced with oxytocin can be seen. 
TABLE 15 
'THE EFFECT OF AMNIOTOMY 














Although the failure rate following induction with 
oxytocin is numerically decreased when amniotomy is 
carried out, this difference is not statistically 
significant. Subsequent to compiling this thesis, 
however, we have completed further investigations and 
the difference has reached statistical significance 
(p < 0.05). 
Table 16 relates the effect of amniotomy to the 
state of the cervix with the use of prostaglandin F
2
a 
and oxytocin in induction of labour. 
TABLE 16 
THE EFFECT OF AMNIOTOMY 
RELATED TO THE STATE OF THE CERVIX 





Oxytocin Ripe 7 4 
Unripe 16 9 
Prostaglandin F 2a Ripe 8 7 
Unripe 12 7 
*Oxytocin Ripe 8 8 
Unripe 12 9 
*Prostaglandin F2a Ripe 8 8 
Unripe 12 11 
* Amniotomy at Time of Induction 
It can be seen that the success rate for prosta-
glandin F 2a is much greater with an unripe cervix when 
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arnniotomy is performed. Using the exact method of 
fourfold tables (Armitage, 1971) this is significant at 
the 8% level. 
These results indicate that if the cervix is unripe 
the best success rate is obtained if prostaglandin F 2a is 
used as the oxytocic agent and arnniotomy is performed at 
the time of induction but that this is an effect of the 
rupture of the membranes. 
4.4 . THE INFLUENCE OF RUPTURE OF THE MEMBRANES ON 
VARIOUS PARAMETERS OF LABOUR 
The parameters which were previously selected to 
compare the success rates of induction of labour with the 
2 drugs were studied to determine if either agent had any 
advantage at these stages. Figure 7 below shows the 
+ mean time - the standard deviation taken by the 2 drugs 
to reach these stages. Time is recorded along the 
horizontal axis and the points I.e., A.C. and 5cm dilata-
tion along the vertical axis. There was no statistically 
significant difference for either drug at these points. 
The lower block diagrams at each stage represent those 
cases where rupture of the membranes was carried out at 
the time of induction of labour. The marked shift to 
the left is seen when arnniotomy has been performed and 
this is statistically significant (p < 0.05) for the 
points I.e. and A.C. This demonstrates that elective 
artificial rupture of the membranes statistically 
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4.5 THE QUALITY OF THE LABOUR PRODUCED BY PROSTAGLANDIN F
2
a. 
. AND OXYTOCIN 
The quality of labour activity using prostaglandin F
2
a. 
and oxytocin was compared using the formula of Effer et 
al (1969), shown below. 
I.U.A. = roo S.D. 
-
X 
I.U.A. = Index of Uterine Arrhythmia 
S.D. = Standard Deviation 
-x = Mean 
Twenty intervals of time elapsing from peak to peak 
of consecutive contractions were analysed. The co-
efficients of variation of these 20 intervals were 
calculated. This co-efficient is an index of uterine 
arrhythmia, being higher when the rhythm is more 
irregular. The different degrees of rhythm are 
categorised as follows: 
Category Range 
of Rhythm of I .U .'A . 
Very regular 0 - 15 
Regular 16 - 25 
Irregular 26 - 35 
Very irregular 36 + 
Effer et al (1969) feel that one of the clinical 
applications of the index of uterine arrhythmia is the 
evaluation of the response to drugs which modify uterine 
contractions. Table 17 below shows the pattern 
description for the 2 groups. 
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TABLE 17 -
THE QUALITY OF LABOUR 
PRODUCED BY THE 2 DRUGS 
Drug Used Pattern Description 









There is clearly no difference in the quality of 
the labour produced by prostaglandin F2a and oxytocin. 
It has also been found that rupture of the membranes may 
cause hypertonus when prostaglandin is used to stimulate 
labour (Roberts & Turnbull, 1971). The effect of 
amniotomy on the quality of labour produced by prosta-
glandin F2a and oxytocin is shown in Table 18 below: 
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TABLE 18 
THE EFFECT OF AMNIOTOMY 
ON THE QUALITY OF LABOUR 
PRODUCED BY OXYTOCIN AND PROSTAGLANDIN F2a 
Drug Used Pattern Description 
Regular Irregular Very Irregular 
Oxytocin 
Without R.O.M.* 8 7 6 
With R.O.M. 12 6 2 
Prostaglandin F2a 
Without R.O.M. 6 9 5 
With R.O.M . 13 4 3 
* R.O.M. = Rupture of Membranes 
It can be seen that rupturing the membranes does 
not produce irregularity of uterine activity compared to 
cases where they are left intact. 
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4.6 MATERNAL BIDE EFFECTS STUDIED 
The side effects studied are listed below: 
1. Changes in urea and haematological changes which 
included the total white cell count and a 
differential count. 
2. Changes in blood pressure. 
3. Changes in temperature. 
4. Instances of vomiting. 
5. Instances of diarrhoea. 
6 . 'Phlebitis'. 
7. Urinary output. 
4.6.1 CHANGES IN THE BLOOD UREA 
The mean and standard deviation of the blood urea 
levels in the 2 groups with and without rupture of the 
membranes is shown in the tables below. Table 19 shows 
the group where the membranes were electively ruptured 
at induction. There was no difference between the 2 
groups before delivery. There was, however, a 
significant difference after delivery. Where prosta-
glandin F2a was used for induction the blood urea value 






BLOOD UREA VALUES IN THE 2 GROUPS 
(AMNIOTOMY PERFORMED) 
Prostaglandin F 2 a Oxytocin 
Before After Before 
Delivery Delivery Delivery 
mg% mg% mg% 
15.7 19.2 17.8 






Where the membranes were not ruptured at the time of 
induction there was no significant difference in the 




This is shown in Table 20 below: 
TABLE 20 
BLOOD UREA VALUES IN THE 2 GROUPS 
(AMNIOTOMY NOT PERFORMED) 























Following rupture of the membranes the statistica} .. ly 
significant rise in the blood urea in the prostaglandin 
group (p < 0.05) as opposed to the cases where oxytocin 
was used, suggests that prostaglandin F 2a does not cause 
water retention. 
4.6.2 THE INCIDENCE OF DIARRHOEA 
The incidence of diarrhoea in the 2 groups is shown 
below: 
TABLE 21 
· THE 'INCIDENCE OF DIARRHOEA IN THE 2 GROUPS 
Oxy tocin 
Prostaglandin F2a 








There was no significant difference between the 
effects of the 2 drugs on the amount of diarrhoea 
produced. 
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4. 6. 3 · 'THE INCIDENCE' OF VOMIT'ING 
The number of patients who vomited in each group 




. 'THE 'INCIDENCE 'OF VOMITING 
'IN THE 2· GROUPS 






There was no significant difference between the 
effects of the 2 drugs on the incidence of vomiting. 
4. 6. 4 . THE 'INCIDENCE OF . 1 PHLEBIT'IS ' 
The colour plate below shows the appearance of the 
transient red line in the skin along the area draining the 
infusion site in a patient receiving prostaglandin F 2a . 
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· 'PLATE SHOWING THE RED LINE DRAINING THE INFUSION SITE 
· CAUS'ED BY 'PROSTAGLANDIN F ~:..=;..=.:;_...,;::.;;;..~~.;;;..;;..;;.;;.;;...;.;;.;;;...;...~;.;_~2a 
The incidence of rphlebitis' which occurred in the 
2 groups is shown in Table 23 below: 
TABLE 23 
. THE 'INCIDENCE OF I PHLEBITIS' 
. 'IN THE ·2 'GROUPS 
Total No. of Cases 
'Phlebitis' 
Prostaglandin F 














The difference in the incidence of 'phlebitis' in 
the 2 groups is statistically significant (p < 0.001). 
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4.6.5 HAEMATOLOGICAL EFFECTS 
(a) Haemoglobin 
Table 24 below shows the mean± standard deviation 
for the haemoglobin levels before and after delivery in 
the 2 groups. There were no significant differences 
between the 2 groups. 
TABLE 24 
PRE- AND POST-DELIVERY HAEMOGLOBIN LEVELS 
IN THE 2 GROUPS 
Haemoglobin Prostaglandin F2 a Oxytocin 
Before After Before After 
Delivery Delivery Delivery Delivery 
g% g% g% g% 
MEAN 12. 9 8 13.00 13.06 13.02 
S.D. 1.19 1. 31 1. 07 1. 35 
(b) ·Total White Cell Count, Differential Count and 
Platelet Count 
Table 25 below shows the mean± standard deviation of 
the total white blood cell count, differential count and 
platelet count in the _ 2 groups before and after delivery. 

































































































































































































































































































































































































































4. 6. 7 . 'PULSE 'RATE, RESPIRATION AND BLOOD PRESSURE 
No difference was found in maternal pulse rate, 
blood pressure and respiration between the oxytocin and 
prostaglandin F 2 a treated groups. 
factors are shown in Table 26 below: 























































































































































































































































































































































































































































































































































































































































4.7 'FETAL SIDE 'EFFECTS 
Fetal heart rate patterns were recorded by external 
cardiotocography. Fetal scalp sampling was not 
performed as the membranes were intact in the first phase 
of the trial. Further, it was felt that the passage of 
an arnnioscope might interfere with the rate of cervical 
dilatation. Table 27 below gives the description of the 
fetal heart rate patterns which were obtained: 
TABLE 27 
FETAL HEART RA'rE' PATTERNS 















Abnormal Change= Late deceleration in relationship 
to contractions or loss of beat to 
beat variation. 
Benign Change = Any other alteration of the fetal 
heart rate pattern. 
All infants in this study were born in good biologi-
cal condition and the mean fetal Apgars recorded at 1 
minute and 3 minutes were satisfactory and the mean fetal 
and placental weights of both groups were the same. 
73 
4. 8 COMMENTS ON RESULTS OBTAINED ABOVE 
A very carefully controlled physiological study has 
been performed. Eighty-three patients are reported. 
This number is smaller than many huge computer studies on 
labour but it is felt to be more meaningful. The 
patients were carefully selected and matched for the 
factors affecting inducibility. Each patient was 
'specialled' by a trained research midwife ensuring 
accuracy of all data recorded. All cervical changes 
were personally assessed by the author every 2 hours 
throughout this thesis. 
Comparable dosage schedules of prostaglandin F2a 
and oxytocin were determined before starting the trial 
for the reasons outlined on page 45. Embrey ( 1969) 
commented on comparable effects of prostaglandins and 
oxytocin on uterine activity at term. He found , 
however, that infusions of prostaglandins in the range of 
4 to 8 µg per minute were roughly comparable with the 
response to the infusion of 5 m-u of oxytocin per minute. 
He commented, however, on an important qualitative 
difference in that at this level of comparability the 
initial action with the prostaglandins was slow (15 to 20 
minutes) compared with the latent period for oxytocin 
which acted almost immediately. The oxytocin regimen 
which we used was similar to that described by Turnbull & 
Anderson (1968). 
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No statistical difference was found in the success 
rates for induction of labour between the 2 drugs, no 
matter whether the cervix was classified as unripe or 
ripe. The prostaglandins were, however, better 
numerically. The only advantage with prostaglandin F2a 
over oxytocin is where the membranes are ruptured and 
the cervix unripe. We selected various parameters in 
labour by which to judge the success of the 2 induction 
techniques. Embrey & Anselmo (1962) felt that the 
latent period from the start of the induction to the 
onset of labour was a useful yardstick by which to 
compare success in induction. We called this point I.e. 
(Initial Contractions). The author felt, however, that 
this alone is inadequate, as it does not necessarily 
imply that induction has occurred, and that a point 
indicating established labour was necessary. Once pain 
was experienced by the patient at the time of uterine 
contractions the uterine pressure, recorded directly 
intra-arnniotically, was found to average 35mm of mercury 
(Scher & Baillie, unpublished observations). This 
pressure is within the range of peak pressures described 
in standard text books (Turnbull, 1957; Chassar Moir & 
Myerscough, 1971) for early first stage of labour and it 
indicates a satisfactory response to induction. This 
was the point referred to as A.C. (Adequate Contractions). 
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The endpoint of the trial - 5cm - was selected because 
this is already beyond Friedman's phase of maximum slope 
(Friedman, 1967) and at this stage the patient is 
unquestionably in labour. Cervical dilatation did not 
occur until effacement was complete. 
Rupturing the membranes at the time of induction 
statistically significantly increased the induction 
success rate when prostaglandin F2a was used. When 
oxytocin was the agent used the improvement was a 
numerical one only. Amniotomy did accelerate labour 
using the parameters of assessment discussed above. 
There is a paucity of physiological prospective studies of 
the effect of rupturing the membranes on the course of 
labour in the world literature and the published articles 
deal mainly with the problem of infection (Calkins, 1934; 
King, 1940; Keetel et al, 1940; Tennant & Block, 1954) . 
The findings in this thesis of a beneficial effect from 
amniotomy on the course of labour is in disagreement with 
the findings of Friedman (1967) who found that amniotomy 
caused arrest of cervical dilatation in 82% of 61 
amniotomies performed in the stage of rapid dilatation 
of the cervix. Friedman states 'this clearly serves to 
illustrate the general inefficiency of this ostensibly 
stimulatory device'. Friedman states that the status of 
the membranes does not seem to influence the course of 
labour and in fact found that more rapid dilatation in 
the active phase in multiparous labour does seem to occur 
when therapeutic amniotomy is not done. He does state, 
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however, that this does require further examination. In 
nulliparous patients, whom we have studied in this thesis, 
he found significant lengthening of the latent phase when 
the membranes ruptured during the latent phase. He 
concluded that it must be asserted that amniotomy in the 
latent phase is detrimental to the course of labour in 
that the latent phase in such cases tends to be signifi-
cantly prolonged. Friedman felt, however, that a 
definitive controlled study of artificial amniotomy (for 
the purpose of induction) is needed to test this effect 
on the duration of the latent phase in labour. A 
possible reason for the conflicting results which 
Friedman obtained may be that they come from a large 
computer study involving every case entering the ward. 
Amongst these undoubtedly would be many cases with early 
rupture of the membranes associated with abnormal 
positions and dysfunctional uterine activity. There 
would be some cases conforming to findings in this thesis. 
But if one puts them all together and averages them all 
out no effect on labour may be found. This is a fault 
of all major computer studies as opposed to a smaller 
physiological study. Donald (1969) feels that there are 
many advantages of intact membranes during labour and that 
active retention of the fetus as a result of tonic uterine 
contractions cannot occur and that fetal asphyxia is less 
likely with intact membranes. We did not find that 
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rupture of the membranes led to hypertonus nor an 
incidence of fetal distress. No patient induced either 
with prostaglandin F2a or oxytocin developed a genital 
infection. This is in agreement with other reported 
series (Calkins, 1934; King, 1940; Keetel et al, 1940; 
Tennant & Block, 1954). Aseptic techniques were 
adhered to throughout the study. 
The quality of the labour produced by the 2 drugs 
was identical. This also applied after elective 
amniotomy. This is contrary to the findings of Roth-
Brandel & Adams (1970) who found that prostaglandin 
produced an abnormal quality of labour which they felt 
might even prevent it from being used for the induction 
of labour. 
A high incidence of diarrhoea and vomiting has been 
ascribed to the prostaglandins. As regards the 
incidence of diarrhoea the author discovered that 37 of 
the patients in the prostaglandin group and 36 of the 
oxytocin series had an enema on the night prior to 
induction. This is routine practice in some midwifery 
units and should be borne in mind when assessing side 
effects. Further, it must be remembered that these 
early results came from initial toxicity studies using 
infusion rates higher than necessary for the induction of 
labour at term (Beazley, 1971). The only side effect 
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which we found to be statistically significant was the 
incidence of 'phlebitis' at the site of injection of 
prostaglandin F2a. This was transient and did not cause 
the patient any discomfort. The finding that induction 
of labour at term by prostaglandins has few complications 
is entirely in .agreement with that of Beazley (1971). 
No abnormalities of the fetal heart rate pattern 
were detected, except in 1 patient whose cardiotocograph 
tracing is shown below in Figures 8 and 9. This case 
was encountered during the preliminary series on 
comparable dosages of prostaglandins. The patient 
developed late decelerations (Type 2 dips - Caldeyro-
Barcia et al, 1966) in the fetal heart rate pattern 
during a prostaglandin infusion. On stopping the 
infusion the pattern became normal. On commencing an 
infusion of oxytocin in the same patient, however, the 
abnormal pattern recurred, and it once again disappeared 
on discontinuing the infusion . This reinforces the 
concept that it is the feto-placental reserve which is 
important in determining the response of the fetus to 
labour (Scher & Baillie, in press). 
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FIGURES 8 AND 9 
TYPE 2 DIPS 
FOLLOWING INTRAVENOUS PROSTAGLANDIN F 2
·a AND OXYTOCIN 




OXYTOCIN 16 m.U/minute 
+ t 6 ~ 
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The work of Roberts et al (1970) suggests that 
prostaglandins as compared to oxytocin have no anti-
diuretic effect, a disadvantage of oxytocin. Corrobora-
tory evidence for this has been shown above by the 
finding that the blood urea was significantly higher in 
the prostaglandin treated patients compared to the 
oxytocin group, which suggests that the latter may have 
retained fluid. Like Roberts & Turnbull (1970) the 
author felt that this aspect needed further careful 
investigation, especially as the state of hydration of 
the patient prior to induction is critical. These cases 
include patients suffering from pre-eclampsia and those 
with cardiac and renal disease. A fluid balance study 




A COMPARISON BETWEEN THE EFFECTS OF 
PROSTAGLANDIN F 2a AND OXYTOCIN DURING 
INDUCTION OF LABOUR IN PATIENTS SUFFERING 
FROM CLASSICAL PRE-ECLAMPSIA 
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5 • l · 'INTR:ODUCT'I'ON 
Oxytocin is anti-diuretic (Gupta & Cohen, 1972) and . 
prostaglandins therefore may well be specifically indica-
ted for induction of labour in cases where fluid retention 
is a problem. Although this has been suggested (Roberts 
et al, 1970; Roberts, 1970; Scher et al, 1972), an 
adequate comparison is not available. No scientific 
conclusion could be drawn from the results of our fluid 
balance measurement in the first attempt at assessment 
described above. Therefore a study was designed to test 
this effect by comparing water retention in cases of 
classical pre-eclampsia being induced with prostaglandin 
F2a and oxytocin. 
5. 2 • MATERIAL 
The principle aims of the study involved careful 
selection of primigravid patients suffering from classi-
cal pre-eclampsia. 
selection: 
Rigid criteria were established for 
(a) Blood pressure of more than 140/90 mm of mercury on 
at least 2 occasions. 
(b) Proteinuria in a midstream urine specimen of an 
amount appropriate to the hypertension. 
(c) Occurrence of features (a) and (b) above after the 
28th week of pregnancy with escalating signs and 
symptoms. 
(d) No past history of renal disease or hypertension. 
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Seventeen patients suffering from classical pre-
eclampsia and requiring induction of labour were studied. 
5.3 METHODS 
5. 3 .1 OBS'ERVATIONS PRIOR TO INDUCTION 
All patients were hospitalised for at least 3 days 
prior to induction of labour. All had the same history, 
examination and investigations performed. Accordingly, 
it was possible to establish a certain protocol or trial 
form. This trial form lists the serial blood and urinary 
investigations for each patient (See Appendix C). In the 
ward strict intake and output measurements were made and 
recorded. The patients were weighed daily and in addi-
tion to a full blood count the following renal function 
tests were performed: 
(a) Midstream urine specimens were examined for protein, 
sugar, white and red blood cells and casts. In 
addition, an ·attempt was made to culture organisms 
from the specimens. 
(b} Two creatinine clearance tests were performed. 
(c) Daily serum and urinary osmolalities were measured, 
as well as daily serum and urinary electrolytes. 
(d) Estimates were made of the blood levels of urea, 
serum glutamic oxaloacetic transaminase, alkaline 
phosphatase, total bilirubin, serum albumin and the 
total serum proteins. 
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5. 3. 2 · OBS'ERVATI'ONS' 'AT 'INDUCTION 
After being transferred to the labour ward the 
patient was weighed. All the inductions were personally 
done by the author . The membranes were ruptured by the 
method described on page 42 and the volume of liquor 
measured by draining it into a bedpan. Comparable doses 
of either prostaglandin F2a and oxytocin were infused 
according to the schemes described above on page 49. An 
in-dwelling Foley's catheter was inserted. The last 6 
patients in the trial received continuous lumbar epiqural 
analgesia as it was felt that the degree of pain exper-
ienced by the patient may affect urinary output by promo-
ting the stress release of anti-diuretic hormone from the 
posterior pituitary gland (Turnbull, personal communica-
tion). 
5.3.3 OBSERVATIONS DURING LABOUR 
The patients were 'specialled' by the research 
midwife. Their vital signs were monitored. Uterine 
contractions and the fetal heart were recorded continuous-
ly by means of an external cardiotocograph. Every 30 
minutes the urinary volume was recorded and the osmolality 
was measured by the freezing point depression method on a 
Knauer Halbmikro-osmometer. 
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Venous blood was sampled from the anterior cubital 
vein every 3 hours and the serum osmolality measured by 
the method described above. 
was measured every 3 hours. 
The creatinine clearance 
These measurements and 
recordings were kept for at least 6 hours of labour. 
5. 3. 4 OBSERVATIONS AFTER DELIVERY 
Blood and urine samples were collected from the 
patients 12 hours after delivery for osmolality and 
electrolyte estimations. 
5 . 3. 5 .RESULTS 
All patients were delivered within 18 hours and all 
neonates were in good biological condition. 
The mean total doses of oxytocin and prostaglandin 
F2a administered conformed to the equivalent dosage 
schedules. 
The fluid balance (ml/hour) results in the prosta-





EFFECT· OF OXYTOCIN AND PROSTAGLANDIN F2a 
ON WATER BALANCE DURING INDUCED LABOUR (ml/hour) 
Case No. Intake Output Balance 
1 97 21 + 76 
2 98 22 + 76 
3 55 56 1 
i:::: 
·.-I 
4 C) 134 54 + 80 0 
.µ 
>t 5 154 24 +130 ~ 
0 
6 70 13 + 57 
7 138 59 + 79 
8 90 19 + 71 
Mean 100.5 33 . 5 + 71 
9 26 30 4 





84 25 + 59 
i:::: 13 27 42 - 15 ·.-I 
"d 
i:::: 14 44 20 + 24 co r-i 
tJ) 
co 15 43 28 + 15 .µ 
Ul 
0 16 171 26 +145 ~ 
Pl 
17 75 41 + 34 
Mean 61 29 + 32 
P<0.05 NS NS 
The intake of the oxytocin group was on an average 
39.5 ml/hour more than that of the prostaglandin group. 
This was the only significant difference established in 
the entire study. There was no difference between the 
urinary output of the 2 groups. The osmolality of the 
urine passed (milli-osmoles/litre) is listed below in 
Table 29. There was no difference between the 2 groups. 
There was no difference between the osmolar clearances 
before and at induction. The mean osmolar clearance for 
+ oxytocin was 1.313 - 0.56 osmoles/minute and the mean 
osmolar clearance for prostaglandin was 1.307 ± 0.28 
osmoles/minute. 
at all. 













































































































































































































































































































































































































































































































































































































































































































The quality of the urine passed by all cases was the 
The fluid load was greater in the oxytocin group 
yet these patients passed the same amount of urine as the 
patients who received prostaglandins. The design of the 
experiment may well have been to give the same fluid load 
to both groups but as the primary object was to induce 
labour it was felt that this method was more applicable 
clinically. Although this is the first study comparing 
the effects of prostaglandin and oxytocin on fluid balance 
in classical pre-eclamptics it does support the work of 
Roberts et al (1970) which shows that oxytocin is anti-
diuretic compared to prostaglandin F 2a. A greater amount 
of water was retained when oxytocin was used to induce 
labour than when prostaglandin F 2a was used. 
Again, the finding in the first section of this 
thesis that when prostaglandin F 2a was used for induction 
of labour the blood urea rose after delivery compared with 
oxytocin inductions where it fell slightly (See page 64) 




THE ROLE OF PROSTAGLANDINS 
IN SPONTANEOUS LABOUR 
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6 • 1 'INTRODUCTION 
Karim (1966) and Karim & Devlin (1967) have shown 
that prostaglandin F2a is present in human amniotic fluid 
obtained during labour and that prostaglandin F2a appears 
in the maternal venous blood in variable amounts during 
labour (Karim, 1968a). This work has prompted the 
suggestion that prostaglandin F2a may play a part in 
parturition. Further evidence for this role is suggested 
by the successful use of prostaglandin F2a to induce 
labour (Karim, 1968a; Karim et al, 1968; Karim et al, 
1969b; Scher et al, 1972). 
Spontaneous uterine activity and the uterine activity 
developed with appropriate doses of oxytocin are identi-
cal to usual parameters of measurement (Karim et al, 
1969b). As it has been shown that the uterine activity 
obtained with oxytocin and prostaglandin F2a is identical 
it provides further evidence that prostaglandin F2a may 
have a physiological role in labour. 
Liggins et al (1972) have discussed a possible 
physiological role of prostaglandin F2a in the mechanism 
of the onset of labour in sheep. Karim (1972) has 
discussed evidence supporting a role for prostaglandins 
in spontaneous labour and abortion. The author decided 
to test for further evidence of the role of prostaglandin 
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F 2a in parturition. 
It was felt that it may be impli-
cated in the acceleratory phase of labour, as it had been 
noted that beta-adrenergic agents are not successful in 
stopping premature labour once the stage of rapid cervical 
dilatation has been reached (Baillie et al, in press). 
The cause of the augmented uterine activity is uncertain, 
but it is known that prostaglandins augment uterine 
activity (Gillespie, 1972), and that it is possibly due 
to stimulation of oxytocin secretion by the maternal 
pituitary (Gillespie et al, 1972). Karim (1968a) has 
also demonstrated that prostaglandin F 2a appears in the 
blood during labour in close relation to uterine contrac-
tions. 
As a result, the author decided to test the effect 
of Orciprenaline, a beta-adrenergic agent, on prosta-
glandin F 2a and oxytocin induced uterine activity in vivo 
at term in the same patient, to assess whether the effect 
of beta-adrenergics was consistent with the hypothesis 
that prostaglandins are implicated in the stage of rapid 
dilatation of the human cervix. Attention was thus 
directed towards an area where ready application to clini-
cal medicine might be available, as most cases of prema-
ture labour are admitted in the acceleratory phase of 
labour, and hence are resistant to beta-adrenergic treat-
ment (Baillie, personal communication). 
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6 • 2 · 'MATERI'AL'S' 'AND METHODS 
Ten patients with clinically normal cardiovascular 
systems in whom labour was being induced at term for 
epidemiological reasons were studied. 
An amniocentesis was performed and a cannula (90cm 
Portex Epidural Cannul~, ref. 100/380/010) was passed 
into the amniotic cavity, the intra-uterine pressure 
being recorded by means of a Hewlett Packard pressure 
transducer, number 1280B, used in conjunction with a 
Hewlett Packard transducer adaptor 1513713, connected to 
a Hewlett Packard cardiotocograph 8020A. Fifty mg of 
Pethidine was administered intravenously and labour was 
randomly induced with oxytocin or prostaglandin F2a' 
using a constant rate infusion pump. Comparable dosage 
schedules of the 2 drugs were used as discussed earlier on 
page 74. 
When the uterine activity was compatible with early 
established labour i.e. at least 150 Alexandria units 
(El-Sahwi et al, 1967), 0.25 mg of Orciprenaline was 
administered intravenously. The effect on uterine 
activity, maternal pulse rate (recorded continuously 
phonocardiographically) and maternal blood pressure 
(auscultated repeatedly) was noted. When the uterine. 
activity returned to the original level, the first drug 
was discontinued and the other substituted. 
procedure was then repeated. 
The whole 
94 
At the conclusion of the experiment the membranes 
were ruptured and labour was allowed to continue. In 
only 1 case (number 4) was the cervix more than 4cm 
dilated. All cases were delivered vaginally within 18 
hours and all neonates were in good biological condition. 
The effect of Orciprenaline on uterineactivity, 
maternal pulse rate and maternal blood pressure in oxyto-
cin and prostaglandin F2a induced labour was then compared. 
6. 3 · 'RESULTS 
The effect of Orciprenaline on the pulse rate, blood 
pressure and uterine activity after stimulation with 
oxytocin and prostaglandin F 2a respectively is seen in 





































































































































































































































































































































































































































































































EFFECT OF ORCTPRENALINE ON UTERINE ACTIVITY* 
· AFTBR OXYTOCIN 
Uterine Activity* 
BL = Baseline tension 
Time to 
Initial Lowest Stable Stability (min) 
227 16 221 18,0 BL 5 BL 3 BL 5 
251 28 231 94,0 BL 10 BL 8 BL 6 
112 32 147 42,0 BL 12 BL 8 BL 8 
Delivered 
196 25 200 51,0 BL 9 BL 6 BL 6 
206 20 198 48,0 BL 8 BL 5 BL 5 
230 0 205 31,0 BL 9 BL 7 BL 9 
220 75 213 18,5 BL 21 BL 7 BL 9 
234 0 258 48,3 BL 5 BL 2 BL 3 


















































































































































































































































































































































































































































































































EFFECT OF ORCIPRENALINE ON UTERINE ACTIVITY* 
AFTER PROSTAGLANDIN F 
~~~~~~~~~~~2a 
Uterine Activity* 
BL= Baseline tension 
Time to 
Initial Lowest Stable Stability 
(min) 
251 0 267 16.0 
BL 12 BL 15 BL 12 
177 42 262 18,0 
BL 20 BL 15 BL 18 
159 12 146 16,5 
BL 18 BL 12 BL 15 
184 0 264 44,0 
BL 8 BL 3 BL 3 
192 13 235 23,0 BL 17 BL 9 BL 12 
200 10 240 28,0 BL 20 BL 10 BL 15 
470 43 417 29,0 BL 18 BL 20 BL 18 
189 151 281 14,5 BL 20 BL 12 BL 19 
347 0 225 20,0 BL 3 BL 3 BL 7 
209 0 296 25,5 BL 5 BL 3 BL 7 
· 238±98 27±47 263±68 23,5 ±8,8 
BL14± 7 BL9± 6 BL13± 5 
* Alexandria units 
99 
There was no difference in the effect of Orciprena-
line on the cardiovascular variables, pulse rate and 
blood pressure, when labour was induced with prostaglandin 
F 2a and oxytocin. Maternal tachycardia and an increase 
in blood' pressure were noted in all. From the initial 
pulse rate and blood pressure recordings in Table 32, it 
appears that there is no alpha-adrenergic effect of the 
prostaglandin at the dosage used. Tables 31 and 33, 
however, show a clear difference in effect on uterine 
activity. Uterine activity was abolished for signifi-
cantly longer periods when the contractions were induced 
using oxytocin, in spite of an initially higher level of 
uterine activity in the prostaglandin series (288 
Alexandria units as opposed to 205 Alexandria units for 
oxytocin). This applied to every case. Figure 10 
shows this effect in 1 patient. 
FIGURE 10 
'EFFECT OF 'ORCIP'RENALINE ON UT'ERINE ACTIVITY AND MATERNAL 
HEART RATE FOLLOWING PROSTAGLANDIN F · AND OXYTOCIN -----------..;;...---------2a--------
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6.4 COMMENT 
The finding that Orciprenaline was not as effective 
in stopping uterine activity in cases induced with prosta-
glandin F2a, as opposed to oxytocin, is further evidence 
for a role of endogenous prostaglandins in spontaneous 
labour and prostaglandin F 2a may be implicated in the 
acceleratory phase of labour. This supports the evidence 
mentioned in the Introduction, on page 92, which is 
already available for the role of prostaglandins in 
spontaneous labour and abortion. Prostaglandin E and 
prostaglandin F 2a are present in human amniotic fluid 
samples obtained during labour or spontaneous abortion 
only (Karim, 1966; Karim & Devlin, 1967; Karim & Hillier, 
19 70) • 
In addition, the same prostaglandins are present in 
the maternal circulation in high concentrations during 
labour and spontaneous abortion (Karim, 1968 a,b, 1970a; 
Karim & Hillier, 1970). Labour and abortion can both be 
induced with prostaglandins (Karim et al, 1969b; Beazley 
et al, 1970; Embrey, 1970; Karim et al, 1970; Karim & 






7.1 'THE 'PROS'TAGLANDIN USED 
The discovery of the biosynthetic production of 
the primary prostaglandin compounds and their total 
chemical synthesis enabled these substances to be studied 
extensively in many laboratories. This led to an 
exhaustive literature on the functional significance of 
the prostaglandins in most of the body systems. For 
information on these systems the reader is referred to 
the many articles and monographs available (Vogt, 1958; 
Eliassen, 1959; Horton, 1965, 1968, 1969; Bergstrom, 1966, 
1967, 1973; Pickles, 1967; Von Euler & Eliassen, 1968; 
Bergstrom & Samuelsson, 1968; Bergstrom et al, 1968). 
The effects of prostaglandins of the E and F series 
on the non-pregnant human uterus have been studied in 
vitro (Bygdeman, 1967; Eglington et al, 1963; Pickles & 
Hall, 1963; Pickles et al, 1965) and on human pregnant 
myometrium both in vitro (Embrey & Morrison, 1968) and 
in vivo (Embrey, 1969). It was shown by Embrey (1969) 
that both the E prostaglandins and those of the F series 
stimulate myometrial activity of the pregnant uterus, 
although the E prostaglandins have an inhibitory action 
in the non-pregnant state which, he felt, emphasised that 
the effect of a pharmacological agent is influenced by 
the physiological state of the organ. 
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Prostaglandin F2a was used in this study as it was 
the only prostaglandin available to the author at the 
conunencement of his research. 
Along with PGE 2 the F prostaglandins probably have 
a physiological role in labour (Karim, 1966; Karim & 
Devlin, 1967; Karim, 1968b; Embrey, 1969). Equally, at 
this time it was the only prostaglandin that could be 
assayed satisfactorily (Hillier, personal conununication). 
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7 • 2 DESTGN OF STUDY 
A great deal of care was taken in the design of this 
study in order that real comparisons could be made and 
scientific conclusions drawn. The cases were carefully 
selected with particular attention to the factors 
affecting the response to the induction of labour. For 
this reason only primigravidae were studied. When 
comparisons were made there was no statistical difference 
between the 2 groups of patients for these factors. 
Beazley & Gillespie (1971) felt that meaningful conclusions 
could not be drawn without using matched cases. 
The patients were 'specialled' during labour by a 
single trained research midwife, and all cervical 
assessments were personally carried out by the author. 
This individualisation of cases minimises observer error 
which must be a fault of larger computer series. 
Prior to comparing the effects of prostaglandin F2a 
and oxytocin, comparable dosage schedules of the 2 drugs 
were derived. The failure to do this is a fault of other 
similar studies (Dewhurst, 1~72), and may account for the 
widely varying results obtained. 
105 
The equivalent dosages were derived using in-patient 
control under the conditions where the drugs are used 
i.e. induction of labour at or near term. These 
stringent demands should be met when drug dosages are 
derived. .Common errors are: 
(a) Not using in-patient control, as the effects of 
oxytocics vary widely from patient to patient. 
(b) Not using an in vivo situation comparable to clinical 
usage, as it is fruitless to compare an in vitro with 
an in vivo situation because of the differing physio-
logical states, or even one clinical situation to 
another which is apparently closely analagous. Even 
more fallacious is the attempt to relate to clinical 
work findings derived from either in vitro human 
studies or any animal studies, whether in vitro or in 
vivo. This lack of correlation is well established 
and reviewed (Pauerstein & Zauder, 1970; Pulkinen, 
1970). 
Standard fluid balance recordings were kept during 
the study. It became apparent, however, on analysing 
the results that no conclusions could be drawn. As a 
result a further more careful study was designed. Again, 
the testing of comparable doses of drugs in conditions 
associated with fluid retention has not been performed 
I 
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previously. Roberts et al (1970), although doing a 
good fluid balance study, did it on 6 normal patients 
in mid-pregnancy who are different from pre-eclamptics 
(Hytten & Leitch, 1971). 
The original protocol form for this study has been 
re-designed to ensure that patients receive an equal 
amount of fluid before and during the trial. 
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7.3 DOSAGE -SCHEDULES' OF PROSTAGLANDIN F 'AND OXYTOCIN --------------------2a.--- ----
Since it has been realised that the prostaglandins 
may also be oxytocic numerous papers have appeared 
comparing their efficacy with that of oxytocin (Anderson 
et al, 1971; Beazley & Gillespie, 1971; Craft et al, 1971; 
Vakhariya & Sherman, 1972). 
From these trials no conclusions can be drawn about 
the relative effectiveness of these 2 drugs as comparable 
doses of oxytocin and prostaglandin F 2a were not used 
(Scher & Baillie, in press). Dewhurst (1972) feels this 
is a major criticism of such studies. 
The result of the present investigation would thus 
appear to be of value in that a scientific attempt was 
made to enable 2 drugs to be compared. 
It is fruitless to argue which is the stronger of 2 
drugs. The clinician wants safe delivery and the effects 
of equivalent drugs must be those which provide this. 
Further, as mentioned above on page 106, one cannot 
correlate animal work to human work (Pauerstein & Zauder, 
1970), or even in vitro human work to the clinical 
situation. Thus the author felt it would be important 
to choose a good model using in-patient control to 
establish drug dosages. 
patient. 
Both drugs were tested in each 
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The ratio of prostaglandin F2a to oxytocin is 
3.14:l when comparing potency and this was used in 
devising the comparable dosage schedules described on 
page 49. These 2 drugs are dissimilar and have different 
molecular weights but it nevertheless provides a means 
for comparing them clinically. 
7. 4 · 'SUCCESS 'OF PROSTAGLANDIN F . . IN 'INDUCING LABOUR AT ---------------2a------------
TERM AS COMPARED WITH OXYTOCIN 
The results of the present study show that using 
comparable dosage schedules, prostaglandin F2a is numeri-
cally better in its ability to induce labour at term than 
oxytocin, but this is not at a statistically significant 
level (82% versus 65%) .• This is in agreement with the 
work of Vakhariya & Sherman (1972), although their study 
involved multigravid patients. They achieved a 96% 
success rate with oxytocin and 94% with prostaglandin F2a. 
Beazley & Gillespie (1971) induced labour in 150 patients 
each with prostaglandin E2 and oxytocin. Seventy-three 
per cent of patients in each group were delivered, or 
achieved 5cm dilatation of the cervix within 12 hours of 
the start of the infusion. The patients were not matched 
for factors known to affect labour, however, and amniotomy 
was not performed at induction. 
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Primigravidae treated with prostaglandin E2 were 
successfully induced in 67% of cases and those treated 
with oxytocin had a 69% success rate. Karim (1971), 
however, reported 67% and 56% success rates in 100 
inductions each with prostaglandin F2a and oxytocin 
respectively. However, comparable doses of the 2 drugs 
were not used. No details of how the patients were 
matched were given and a very low maximum dosage of 
oxytocin is described. This obviously biases success in 
induction of labour towards prostaglandins rather than 
oxytocin. Embrey (1970) successfully induced labour in 
23 out of 25 patients at, or near term using prostaglandin 
The success rate for the prostaglandin F2a 
patients with a ripe cervix in this thesis was 94% and 
for the oxytocin group with a ripe cervix 80%. With an 
unripe cervix prostaglandin F2a was successful in 75% of 
cases and oxytocin in 64% of cases. Anderson et al 
(1971) only achieved a 23% success rate using prosta-
glandins E2 and F2a in term induction in multipara with 
Bishop scores of 6 or less. Their titration schedules 
were of a very low order, however, and they subsequently 
improved their success rate by increasing maximum dosages. 
Based on the results of this study the author is convinced 
that prostaglandin F2a is as effective as oxytocin for the 
induction of primigravidae at term, particularly as 
comparable dosage schedules of the 2 drugs were used 
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which was a failure in most other studies (Dewhurst, 
1972). This is to be expected. Differences in the 
incidence of side effects are therefore of crucial 
importance in deciding which drug is superior. 
The dosage schedules devised are not only comparable 
but simple to use, easy to follow, and could easily be 
used by midwives. Thus they have practical significance. 
Conflicting success rates in some studies comparing the 
use of prostaglandins and oxytocin in induction of labour 
may be due to using rather a low dose of 1 drug compared 
to the other. 
7 . 5 'ASSESSMENT OF THE CERVIX 
As mentioned under methodology, all patients were 
assessed by the author for the factors known to affect 
the response to induction. Much emphasis was placed on 
I 
the state of the cervix, a ~ Embrey & Anselmo (1962) had 
shown that the ripeness of the cervix is the most 
influential clinical feature in labour induction using 
I oxytocin. Turnbull & Anderson (1967) concluded that • 
ripeness of the cervix is a major clinical factor affect-
ing the outcome of arnniotomy in labour induction. Further, 
Garrett (1960) felt that the state of the cervix is the 
only sign of practical importance in the prediction of the 
outcome of surgical induction. The author classified 
the cervix as ripe or unripe after Embrey's classification 
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of the primigravid cervix (1962) which is as follows: 
Fa:voura:ble ce·rvix 
1. Cervix more than 2 fingers dilated, partly effaced. 
2. Cervix 1 to 2 fingers dilated, well effaced, soft 
and stretchable. 
un·f a:voura:ble cervix 
1. Cervix long (uneffaced), less than 1 finger dilated. 




All cases not falling into either of the above groups. 
~ The author felt, however, that in primigravidae the 
degree of effacement of the cervix is of major importance 
in assessing the cervix and the response to induction. 
He felt that insufficient attention has been given to 
this in the literature and no reference to an attempt at 
scientific measurement of this factor has been given. 
Bishop (1964) did however, include an assessment of 
effacement as a factor when devising his scheme for 
giving a total pelvic score in order to assess the 
favourability of the outcome of elective induction of 
labour. In this thesis the author regarded the length 
of the primigravid cervix to be 3cm at the onset of labour. 
The technique of measurement is described on page 30. 
'Effacement-grams' besides 'cervico~grams' were kept and 
it was clearly shown that the major portion of the latent 
phase of labour is concerned with cervical effacement. 
Applying statistics to the results it was found that if 
the cervix was not 75% effaced 8 hours after induction 
13 out of 18 cases will not deliver or be 5cm dilated 
within 12 hours as shown in Table 34 below: 
TABLE 34 
RATE OF EFFACEMENT OF PRIMIGRAVID CERVIX 
ON OUTCOME OF INDUCTION 
Cervix 75% 
effaced after 8 hours 
Cervix not 75% 
effaced after 8 hours 
Delivery or 5cm Dilatation 




p < 0 . 001 
This is in complete disagreement with Anderson et al 
(1971) who in discussing induction with prostaglandin 
solutions, found that with a Bishop score of 4 or less 
(unripe cervix) contractions occurred which were strong 
and regular for 6 to 8 hours, without any discernible 
change in cervical dilatation and effacement. The 
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patient would then be found to be 2 to 4cm dilated and 
delivery would occur in the next 1 to 2 hours. They 
felt that this might be representative of the type of 
labour one might expect from prostaglandin inductions in 
difficult cases . The reason for the lack of cervical 
change is not apparent but may be due to the fact that 
the patients in their series were multiparous patients 
(up to para 4) and primigravidae, who are more pre-
dictable, were excluded. Again, in this study the only 
difference in the labour pattern between the ripe and 
unripe cervix was the longer latent phase in the latter 
during which increasing effacement took place. Thus it 
was found that the latent phase of labour between 
induction and the acceleratory phases of labour varies 
with the state of the cervix and that effacement is of 
major importance. Embrey & Anselmo (1962) provide 
corroboratory evidence for this as they felt that the 
latent period between induction and the onset of labour 
varies with the ripeness of the cervix. A modification 
of Embrey's classification was thus devised and employed 
in this study; 
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Favourable ·ce·rvix 
More than 2cm dilated and/or more than 66% effaced . 
Unfavourable Cervix 
Less than 2cm dilated and/or under 66% effaced . 
It is felt that this is more precise in that it 
quantitates, rather than qualitates, effacement. 
Using these criteria to assess the cervix, it can 
be seen from Table 35 that the success rate did vary with 
the ripeness of the cervix. Although no justification 
for a cervical score was found by the author in the 
literature, these findings would lend credence to the 
evidence based on first principles. 
TABLE 35 
EFFECT OF STATE OF THE CERVIX 
ON OUTCOME OF INDUCTION 
State of Cervix 
Unripe Cervix 
Ripe Cervix 







These findings support the work of Embrey & Anselmo 
(1962) mentioned above. A differing definition of 
favourability was derived by them for primigravidae and 
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multiparae . Anderson et al (1971), who did not find the 
state of the cervix significant, did not distinguish 
between them and furthermore, multiparous labour is known 
to be more rapid (Friedman, 1967) . 
Each patient in this thesis was also assessed 
according to Bishop's scoring system (1964) and it was 
found that using this method a score of 9 or more, which 
was a favourable prediction for labour by his criteria, 
agreed with the author's assessment for a ripe cervix, 
using the criteria of ripeness listed above, in only 68% 
of cases. 
This lack of close agreement may be due to several 
factors. No statistical validation of the Bishop score 
was found. The statement that 'experience has convinced 
us that elective induction may be successfully and safely 
performed when the pelvic score totals 9 or more' 
(Bishop, 1964) highlights this contention. A high pelvic 
score, however, is, by first principles, more likely to 
be associated with an easy induction . The factors used 
in any non-parametric scoring system are not equivalent 
and may even be interrelated as is probable in Bishop's 
system with such factors as consistency, position of the 
cervix and engagement of the fetal head. These are 
directly related to effacement of the cervix. For this 
reason, and because of the close correlation found with 
Ernbrey's classification (Embrey, 1962) it was thought that 
cervical effacement was the best available guide to the 
ease of induction of labour. 
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7.6 THE EFFECT OF AMNIOTOMY ON PROSTAGLANDIN AND OXYTOCIN 
INDUCED LABOUR 
Confusion and contradiction punctuate the obstetric 
literature with regard to the influence of the chorio-
amniotic membranes on the course of labour. No true 
physiological prospective studies were found by the 
author in the world literature which used cases matched 
for factors affecting the response to induction, with 
the state of the membranes being the only variable. 
Further, no published study is as yet available on the 
effect of rupturing the membranes on labour induced with 
prostaglandins. 
The results of this thesis show quite clearly that 
elective artificial rupture of the membranes speeds up 
the onset of labour and accelerates the latent phase of 
labour. This enhancement occurs to a statistically 
----significant degree where prostaglandin F2 is the agent a . 
used, and to a numerical degree only when oxytocin is 
used. The reason for this improvement may be the 
pressure of the head on the cervix, acting via Ferguson's 
reflex (Ferguson, 1941). 
Further, it has been shown that rupturing the mem-
branes artificially increases uterine activity (Brotanek, 
1966; Brotanek et al, 1969), and this may be an additive 
factor. 
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Why Friedman (1967) found an adverse effect from 
rupturing the membranes may be that he obtained his 
results from a large computer study involving every case 
entering the labour ward. Amongst these would be 
patients with early rupture of the membranes because of 
abnormal positions and patients with abnormal uterine 
activity. Some cases, however, would conform to our 
results. If all these cases are put together and 
averaged out no effect on labour may be found, which is 
a fault of large computer studies. 
Infection was not encount~red in the cases studied. 
A further advantage to rupture of the membranes is the 
provision of an additional parameter (the appearance of 
the liquor amnii) by which we can monitor the fetus in 
labour . 
7.7 SIDE EFFECTS PRODUCED BY PROSTAGLANDINS 
Many side effects have been reported following the 
use of prostaglandins to induce labour. The main ones 
noted were diarrhoea, vomiting and a red line along the 
area draining the infusion site, which will be referred 
to as 'phlebitis', uterine hypertonus and inco-ordinate 
uterine action (Karim & Filshie, 1970b; Roberts & 
Turnbull, 1971; Roth-Brandel & Adams, 1970). 
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DIARRHOEA 
From the results described above on page 66 it was 
shown that the amount of diarrhoea recorded during 
induction with the 2 drugs was not statistically different. 
Rupturing the membranes also had no effect on this. It 
must be remembered that in some obstetric units patients 
routinely receive an enema prior to induction. This may 
have aggravated the amount of diarrhoea in both groups. 
Prostaglandins occur naturally in the gut wall, however, 
\ and may therefore be involved in normal motor activity of 
J 
~ the gastro-intestinal tract (Bennett, 1971) . Further-
more, prostaglandins are released during peristalsis 
(Bennett et al, 1967; Coceani et al, 1967). A patho-
logical role for circulating prostaglandins on gut 
motility is provided by the possible diarrhoeal effects 
of prostaglandins released from certain tumours (Williams 
et al, 1968). From this evidence it would seem likely 




There was no statistical difference in the amount 
of vomiting between the 2 groups. When the membranes 
were ruptured electively at induction, however, this 
resulted in a significant increase in the amount of 
vomiting in both groups. The reason for this is not 
clear. 
'PHLEBITIS' 
A tissue reaction at the infusion site occurred with 
statistical significance (p < 0.001) in the prostaglandin 
F2a treated group. It appeared as a reddening overlying 
the vein draining the infusion site (See Colour Plate 
page 67). This effect was transient and faded rapidly 
on discontinuing the infusion. Only 1 patient complained 
of a burning discomfort at the infusion site . It was 
not tender to pressure. Hillier & Embrey (1972) used 
higher doses of prostaglandin F2a for induction of 
abortion and obtained the same findings, except that they 
found the prostaglandin F2 a induced reaction caused a 
reddening of the tissues around the infusion site, 
rather than along the vein. The explanation for this 
reaction, which has been variously described as 
'phlebitis', 'venous erythema' or 'chemical vasculitis' 
(Hillier & Embrey, 1972), is not clear. 
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Solomon et al (1968) studied the effect of injected 
PGE 1 on the skin of the fore-arms of 8 he
althy human 
subjects. They found it was a potent vasodilator of 
human cutaneous vessels and its effect was only partially 
dose-dependent, as when the injected dose was lowered 
from 5 µg to 1 µg the reaction was less marked but 
otherwise the same . It caused a transient erythema 
which was tender to pressure. In these patients there 
was an inflammatory streak leading away from the injec-
tion site which they felt may have been due to leakage 
of PGE1 from the lymphatic vessels. 
Greaves et al (1971) have recovered prostaglandins 
E1 , E2 , Fla and F2a from inflamed areas of human skin, 
and they feel that prostaglandins may be mediators of 
human cutaneous inflammation. This is supported by the 
fact that skin from man is capable of prostaglandin syn-
thesis (Jonsson & Ang~rd, 1972; Zibohr et al, 1973). 
BLOOD UREA 
In those cases where the membranes had been rup-
tured electively a statistically significant rise in the 
blood urea occurred after delivery in the prostaglandin 
group as compared to the patients who had received oxy-
tocin. This suggests that prostaglandin F2a was not 
anti-diuretic. Prostaglandin F2a has been identified 
within the renal medulla and there is evidence that the 
reno-medullary prostaglandins may normally participate in 
an anti-hypertensive and naturetic function (Lee et al, 
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1967). The excretion of water may account for the rise 
in blood urea. This may be of great advantage in 
labour induction where fluid retention may be critical. 
There were no statistical differences in the effects 
of the 2 drugs on the haemoglobin level, total white blood 
cell count, differential count and platelet count. Plate~ 
let functions were not performed. 
HYPERTONUS 
Dewhurst (1972) feels that hypertonus is likely to 
occur during prostaglandin infusion in the main circum-
stances discussed below: 
1. An Initial High Dose 
Roberts & Turnbull (1971) reported 4 cases of 
uterine hypertonus following amniotomy in 18 women 
induced at term when given 0.75 - 3 µg per minute of PGE 2 
intravenously; their initial dose was high, however, and 
in 1 case the uterine hypertonus encountered was defi-
nitely due to too high a dose. 
2 . A High Dose Reached by Frequent an'd Large Increases 
Beazley (1971) had found that a latent period of 15 
to 30 minutes exists with the prostaglandins when used 
for labour induction. Embrey (1969) found a latent 
period of 15 to 20 minutes when prostaglandins were 
administered intravenously in late pregnancy. If this 
delay in response is not appreciated, one dose could 
coincide with the next dosage increase and hypertonus 
may therefore result. This effect is illustrated by the 
cardiotocograph tracings on page 51. From these it can 
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be seen that the author overcame this problem by 
observing a 30 minute interval between incremental 
dosages of prostaglandin F 2a. 
Embrey (1969) does not report hypertonus using E and 
F prostaglandins in the only other series where equivalent 
doses of oxytocin and prostaglandin were used, except in 
1 case where ·overdosage occurred ( 8 µg per minute of PGE 2 
was given, the previous range being between 2 - 6 µg PGE 2 
per minute) • 
In this study no hypertonus was encountered using 
prostaglandin F 2a in 43 patients who received it up to a 
maximum dose of 40 µg per minute. Karim (1970), with a 
dose not exceeding 10 µg per minute of prostaglandin F2a 
to induce labour, did not encounter hypertonus in 200 
patients. Beazley & Gillespie (1971) found no hyper-
tonus in 150 patients receiving prostaglandin F2a' even 
though they used a highest dose of 6.7 µg per minute of 
prostaglandin E2 (equivalent to 67 µg prostaglandin F 2a 
per minute) • This strength was reached, however, only 
after 5 increases at hourly intervals. Embrey (1970) 
did not encounter hypertonus in 23 cases at or near term 
using PGE1 and PGE2 to induce labour. 
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Uterine over-stimulation is a potential risk with 
both oxytocin and prostaglandin (Beazley & Gillespie, 
1971) and care must be taken to infuse them cautiously if 
the problem is to be avoided. Anderson et al (1972) 
concur with this view which supports the findings of this 
thesis. 
QUALITY OF LABOUR 
Karim et al (1970) found that the uterine activity 
produced by prostaglandin infusion resembled that of 
normal spontaneous labour and no unphysiological increase 
in uterine tonus was observed. 
Roth-Brandel & Adams (1970), using lower doses of 
prostaglandin F 2a than the author, however, recor
ded 
episodes of inco-ordinate uterine activity. The 
examples illustrated are not convincing. They admit 
that mid-pregnancy may not be equivalent to late preg-
nancy, and in the only example of late pregnancy inco-
ordinate activity occurred after 410 minutes of a 
constant infusion of prostaglandin F2a 0.7 µg per 
minute. If labour had supervened before this time, 
this may well have been an excessive dose. The more 
usual pattern of response, common to prostaglandins F 2a' 
PGE1 and PGE2 , was an initial increase in freq
uency of 




Using the formula of Effer et al (1969), discussed 
on page 60, which is a measure of the quality of labour, 
this was not found. The quality of the labour produced 
was similar to that obtained with oxytocin, whether 
amniotomy was performed or not. 
HAEMATOLOGICAL EFFECTS 
No alteration was found in the haemoglobin, white 
blood cell count, differential count or platelet count of 
any patient tested. A leucocytosis has been reported 
following high dose intravenous prostaglandins F2a and 
PGE2 used for mid-trimester abortion (Hillier & Embrey, 
1972). The doses used, however, are far in excess of 
those used for the term induction of labour. The effects 
of prostaglandins on erythropoeisis are still not certain. 
It has recently been reported, however, that prostaglan-
dins modulate the effects of the hormone erythropoeitin 
on erythroid differentiation in marrow cell cultures 
(Dukes, 1972). 
BLOOD PRESSURE, PULSE RATE AND RESPIRATION 
No significant change was noted in the blood 
pressure, pulse rate or respiration of any patient 
receiving prostaglandin F2a or oxytocin. Karim et al 
(1969a) and Karim & Filshie (1970a) found this to be the 
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case in male volunteers employ ing doses of prostaglandin 
F 2a up to 150 µg per minute. 
These are higher dosages 
than those used in this series. Embrey (1969), using a 
maximal total dose of prostaglandin F2a ' also found no 
changes in these parameters. 
It appears from the lack of effects on the parameters 
discussed above that prostaglandin F2a has a very selec-
tive effect on the pregnant myometrium (Karim et al, 
1969a) • 
'EFFECTS ON THE FETUS 
No abnormalities of the fetal heart rate occurred in 
this study employing either prostaglandin F2a or oxytocin. 
Figures 8 and 9 on page 80 show the cardiotocograph 
tracings from 1 patient which illustrate that it is the 
placental reserve which is important in determining the 
response of the fetus to labour (Scher & Baillie, in 
p ress). 
In sununarising the toxic effects of prostaglandin 
F 2a when compared to oxytocin in equivalent dosages, it 
is reasonable to conclude that the only side effect 
significantly associated with prostaglandin F 2a admini-
stration is the transient 'red line' at the infusion site. 
This agrees with Embrey's findings for prostaglandins E1 
and E2 (1970). 
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7.8 "THE EFFECTS OF PROSTAGLANDIN F . . AND OXYTOCIN ON . . . 2a---------
FLUID BALANCE DURING INDUCT'ION TN PATIENTS 
SUFFERING FROM PRE-'ECLAMPSIA 
Oxytocin is anti-diuretic (Gupta & Cohen, 1972) and 
water intoxication has been reported as a complication 
(Liggins, 1962; Whalley & Pritchard, 1963; Potter, 1964; 
Self, 1966; Silva & Allan, 1966; Lilien, 1968; Josey et 
al, 1969; Goodlin et al, 1969; Bilek & Dorr, 1970; Gupta 
& Cohen, 1972). 
It has been reported that in pregnant women having 
a continuous intravenous infusion of oxytocin, anti-
diuresis starts at an infusion rate of about 15 m-u per 
minute and is maximal at 45 m-u per minute (Abdul-Karim 
& Assali, 1961). The measurement of fluid balance in 
labour presents considerable difficulties because of the 
lack of a steady state. In this study a greater amount 
of water was retained when oxytocin was used to induce 
labour than when prostaglandin F2a was used. The 
metabolic effects of the pre-eclamptic process are 
probably the most important variables in determining the 
amount of fluid retained (Hytten & Leitch, 1971). This 
may account for the wide variation encountered in this 
study, despite great care in selecting cases and in 
establishing comparability before induction. 
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Pain and fear may reduce the renal plasma flow and 
glomerular filtration rate (Hytten & Leitch, 1971). In 
order to avoid this, a lumbar epidural anaesthetic was 
used (Turnbull, personal communication) in cases 4, 5, 
6, 7, 11, 12, 13 and 16. This produced variable results, 
however, the reason for which is not understood. This 
variability of response may be due to the variability of 
dermatone analgesia produced by an epidural block. Renal 
blood flow is probably enhanced by a block extending to 
T8 and T9 (Crawford, 1972), whereas a block extending 
more cranially may well cause sympathetic blockade and a 
decrease in renal flow, on occasion even extending to a 
systemic hypotension (Willocks & Moir, 1968). No 
systemic hypotension was recorded in this series, but 
effects on renal blood flow could not be excluded. 
Another factor which may affect urinary output is 
the position adopted by the pregnant woman. In the 
supine position the pregnant woman shows a decreased 
urine flow, decreased electrolyte excretion, decreased 
glomerular filtration rate and also a decreased renal 
plasma flow. Further, Klopper (1964) noted that the 
reduction in diuresis after a water load when a pregnant 
woman lay on her back versus her side, was particularly 
marked in hypertension. In labour it is particularly 




Isotopic studies were not attempted because it is 
unethical to use isotopes in a pregnant woman. The 
measurement of urine volume and osmolality is the best 
guide to fluid status under clinical conditions (Pitts, 
1968). In this study, despite a significantly higher 
intake of fluid in the oxytocin group, the urinary 
volumes were almost identical. This is contrary to 
expectation if there were no differences between F2a and 
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oxytocin. 'V o-r-t.a;.l,-,u 6 , rt.A. ~ 
Furthermore, as the osmolality of the urine of the 
2 groups was similar, it would appear that water was 
being retained in the oxytocin group, an action compatible 
with an anti-diuretic effect (Strauss, 1957) . This is 
well known for oxytocin (Abdul-Karim & Rizik, 1970), and 
although by no means conclusive, this study offers further 
objective evidence that prostaglandins are superior to 
oxytocin in cases of pre-eclampsia where induction is 
necessary. As a result of difficulty in measuring fluid 
balance in labour a further study has been devised, with 
special attention being given to the initial state of 
hydration and standardisation of the amount of fluid 
given to each patient per unit time. 
7 . 9 · THE 'ROLE UF 'PROST.AGLANDINS' 'IN SPONTANEOUS. LABOUR 
The findings of this thesis suggest that prosta-
glandin F2a has a physiological role 
in the acceleratory 
phase of labour . An in vivo situation was used to test 
this . In order to avoid patient to patient variation 
both drugs were used in the same subject. In the 
titration schedules uterine activity analogous to early 
labour was obtained by using comparable titration schemes 
for oxytocin and prostaglandin F2a . 
formula of which is shown below, 
Orciprenaline, the 
HO CH3 0- <;:H-CH,-NH-CH-CH,-H 
HO OH 
Orciprenaline 
a resorcyl ethanolamine and beta-adrenergic stimulant, 
was less effective in decreasing uterine activity 
stimulated by prostaglandin F2a than by oxytocin
. 
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There are several possible explanations for this. 
Firstly, the effect of the prostaglandin may be on the 
sarcoplasm via a calcium mechanism (Carstens, 1972), 
thereby bypassing the site of action of beta-adrenergic 
agents and oxytocin. Secondly, prostaglandin stimulated 
labour may be less affected by Orciprenaline because of 
the known alpha-adrenergic effect of prostaglandin. 
This effect was not noted, however, as seen by reference 
to the pulse rate in Table 32 on page 98. Thirdly, the 
other possible mechanism is that prostaglandins stimu-
lated oxytocin release, leading to an augmented effect 
(Gillespie et al, 1972) which would be less easily 
depressed by Orciprenaline. 
These findings would conform with the hypothesis 
that the prostaglandins may be implicated in the stage of 
rapid cervical dilatation, as beta-adrenergics are known 
to be less effective in this stage of premature labour 
and the result of this study reinforces the possibility 
that prostaglandins may have a physiological role in 
parturition. Consequently, a new approach in the 
management of premature labour is suggested in that anti-
prostaglandins may be effective at a later stage in 
premature labour, thereby enabling many more cases to be 





SUMMARY AND GENERAL CONCLUSIONS 
The prostaglandins are an important new group of 
local hormones. They have found their first clinical 
application in obstetrics. The clinical role for these 
agents has not been decided and has received inadequate 
scientific consideration. In particular, the place of 
prostaglandins in obstetrics in a country which does not 
} have an abortion law, such as South Africa, has not 
received attention. 
The comparison of the oxytocic properties of 
prostaglandin with oxytocin in the induction of labour 
has not always been undertaken with due regard to 
matching patients for the factors determining a patient's 
response to induction, and, in particular, scant attention 
has been given to using equivalent dosages of the two 
drugs. 
It was thus considered that a study directed towards 
clarifying the true clinical role of prostaglandins in 
obstetrics, and comparing it with oxytocin, should be 
undertaken and was necessary. Accordingly the aims of 
this thesis, as outlined in Part 2, were: 
1. To determine comparable dosage schedules of prosta-
gl·andin F 2 a and oxytocin for labour induction, so 
that real comparisons could be made. 
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2. To determine the success rate of labour induction 
in a physiological study on matched patients 
receiving oxytocin or prostaglandin F2a' initially 
without performing amniotomy, and then subsequently 
to study patients where amniotomy is carried out at 
the time of induction of labour, in order to evaluate 
the effect of rupturing the membranes on labour 
induced by oxytocin or prostaglandin F2a, 
3. To determine if the advantage claimed for prosta-
glandin in induction of labour with an unripe cervix 
is real or spurious, 
4 . To study the side effects which are a supposed 
disadvantage of prostaglandins, namely diarrhoea, 
vomiting, 'phlebitis', hypertonus and abnormal 
uterine action, 
5. To study the effects of prostaglandin F2a and 
oxytocin on the blood urea and blood count, 
6 . To study the effects of prostaglandin F2 a and 
oxytocin on fluid balance in primigravidae suffering 
from classical pre-eclampsia, 
7. To determine the physiological role for prosta-
glandins in spontaneous labour. 
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To provide a background to these studies the 
historical background and chemistry of the prostaglandins 
was reviewed. 
Primigravid patients requiring induction of labour 
were selected and compared for the criteria known to 
influence the response to induction. As there was no 
difference in these criteria in the oxytocin and prosta-
glandin groups, the results obtained could be compared . 
In a separate study equivalent titration schedules 
for oxytocin and prostaglandin F 2 a were determined by 
direct intra-amniotic pressure recordings. These 
practical schedules were used throughout this thesis. 
Following initial evaluation of the criteria of 
inducibility mentioned above, the blood urea, haematocrit 
and total and differential white blood cell counts were 
determined. The carefully selected patients, 83 in 
number, received either prostaglandin F2a or oxytocin, 
depending on whether their folder number ended in an 
odd or even figure. A method of assessing cervical 
ripeness was determined and 'cervico-grams' and 
'effacement-grams' were kept during labour. Parameters 
by which the success rate of different methods of 
induction could be compared were determined. All the 
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patients were constantly 'specialled' by a single 
research midwife and all the cervical assessments were 
performed by the author personally throughout the trial. 
All data were recorded on special trial forms (See 
Appendix A) and the data ultimately transferred to 
computer cards for analysis and statistical evaluation. 
The following results were obtained: 
1. The success rate of induction of labour using 
oxy tocin or prostaglandin F2a ' although numerically 
better with the latter, shows no statistical 
difference. 
2. Prostaglandin F2a is statistically superior to 
oxytocin where an unripe cervix exists and the 
membranes are ruptured, but this is felt to be an 
effect of amniotomy. 
3. Amniotomy significantly enhances the success rate 
of induction with prostaglandin F2a . 
4. There is no statistically significant difference in 
the amount of diarrhoea and vomiting produced by the 
2 drugs. The only significant side effect of 
prostaglandin F2a is a transient red line along the 
area draining the infusion site. 
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5. Prostaglandin F2a produces a normal quality of 
labour. 
6. Arnniotomy statistically significantly accelerates 
labour in both prostaglandin F2a and oxytocin 
induced labour. 
7. The major part of the latent phase of labour in 
primigravid patients is concerned with effacement of 
the cervix, and if the cervix is not 75% effaced 8 
hours after induction 13 out of 18 cases will not 
deliver, or be 5cm by 12 hours. 
8. Neither administering prostaglandin F2a nor oxytocin 
causes a change in the blood urea, haematocrit, 
white blood cell or differential count. 
9. Neither administering prostaglandin F2a or oxytocin 
for labour induction causes a change in the systolic 
or diastolic blood pressure. 
10. This thesis shows that oxytocin is anti-diuretic 
when compared to prostaglandin F2a in the induction 
of labour at term in patients suffering from classi-
cal pre-eclampsia. These 17 patients are not 
included in the 83 inductions described above. 
11. Prostaglandin F2 a is not anti-diuretic when com-
pared with oxytocin in the induction of primigravid 
patients suffering from classical pre-eclampsia. 
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12. The use of a beta-adrenergic agent (Orciprenaline) 
in stopping labour induced with oxytocin or 
prostaglandin F2 a suggests that the latter has a 
physiological role in the acceleratory phase of 
labour. 
A rapidly changing biological equilibrium such as 
the onset of labour, and the factors governing it, is 
difficult to study because many unknown or unquantifiable 
variables affect this equilibrium. 
are therefore difficult to make . 
Precise conclusions 
The following conclusions, however, may be made: 
1 . This carefully controlled physiological study has 
shown that prostaglandins are as effective as 
oxytocin in the routine induction of labour at term 
but have a latent period which must be respected. 
They may be more effective where an unripe cervix is 
found and the membranes are ruptured. 
2. The side effects obtained when using prostaglandins 
are not a major disadvantage. The only significant 
side effect of prostaglandin F2 a is a transient red 
line over the area draining the infusion site . The 
other side effects usually ascribed to prostaglandins 
are thought to have been exaggerated . Further, the 
development of synthetic analogues may overcome these 
side effects. 
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3 . Prostaglandins cause less fluid retention and hence 
must be considered the drug of choice in the 
induction of patients where fluid balance is 
critical e.g. pre-eclamptics, hypertensives and 
patients with renal or cardiac disease. 
4 . Comparable dosage schedules of prostaglandin F2a 
and oxytocin must be used when comparing the 2 agents. 
5. Rupturing the membranes at amniotomy statistically 
significantly imp~oves the success rate of induction 
with prostaglandin F2a . 
6. Prostaglandins may be implicated in the acceleratory 
phase of labour. 
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fART 9 
fUTURE STUDIES OF rROSTAGLANDINS IN OBSTETRICS 
SUGGESTED BY THIS THESIS 
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1. Fluid balance stud~es comparing oxytocin and prosta~ 
glandin with equivalent intakes of fluid. 
2. Similar comparisons of effectiveness in induction of 
labour using PGE1 , PGE 2 and synthetic analogues as 
they become available . Total chemical synthesis 
has been achieved (Corey, 1969) and natural and 
synthetic analogues are being developed which may be 
more successfully used in obstetrics with fewer 
undesirable side effects. 
3 . The use of antiprostaglandins and relaxant prosta-
glandins in the management of premature labour. 
4. The role of prostaglandins in intra-uterine death 
where induction is a problem. A preliminary trial 
has been completed using PGE 2 in cases having an 
intra-uterine death and it suggests that this is a 
useful application for prostaglandins in obstetrics 
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AlO - 12 
Al3 - 14 
Al5 - 18 
Al9 




A27 - 32 
A33 - 38 
A39 - 44 
A45 
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(6) Hospital Number 
(1) Race C· - Coloured 
A - Asian 
B - Bantu 
(2) Age in Years 
(3) Height in ems 
(2) Pre-delivery Weight in Kgs 
(4) Antenatal Haemoglobin 
(1) Primary Indication for Induction 
1 = Raised BP and Albuminuria 
2 = Raised BP 
3 = Prolonged Pregnancy 
4 = Other 
(4) Best Estimated Gestational Age 
i . e. 2 weeks 
1 day 
1 certain 1 or uncertain 2 




(1) Enema Given 1. Yes 
2. No 
3. Unknown 
(1) Oil Given 1. Yes 
2. No 
(6) Average of Last 2 BPs Prior to Infusion 
Systolic Diastolic 
(6) Maximum Systolic and Diastolic BP 
During Infusion 
Systolic Diastolic 
(6) Minimum Systolic and Diastolic BP 
During Infusion 
Systolic Diastolic 
(1) Drug Used 1. Oxytocin 
2. Prostaglandin F 2a 
A46 - 49 
A50 - 53 
A54 - 56 




A62 - 64 
A65 
A66 - 68 
A69 - 71 
A72 - 74 
A75 - 77 

















( 4) Initial Temperature 
( 4) Maximum Temperature During Infusion 
( 3) Initial Cervical Dilatation ems 
(2) Initial Cervical Effacement % 
(1) Station 1 = -3 
2 = -2 
3 = below spines 
5 = unknown 
(1) Initial Consistency 1. Firm 
2. Medium 
3. Soft 




(3) Uterine Activity Prior to Infusion 
(seconds of contraction/10 minutes) 




(3) Commencement of Infusion - I.e. in Minutes 
(3) I.e. - A.C. Interval in Mi nutes 
(3) A.C. - 5 cm Total Interval in Minutes 
(3) Infusion - 5 cm Total Interval in Minutes 
(90) PVs During Infusion 
1 2 3 4 5 6 
(3) A78-80 Bl3-15 B28-30 B43-45 B58-60 B73-75 
(3) Bl-3 Bl6-18 B31-33 B46-48 B61-63 B76-78 
(3) B4-6 Bl9-21 B34-36 B49-51 B64-66 B79-Cl 
( 1) B7 B22 B37 B52 B67 C2 
(3) B8-12 B23-27 B38-42 B53-57 B68-72 C3-7 
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C 8 - 11 (4) Total Amount of Drug at I.C. 
Cl2 - 15 (4) Total Amount of Drug at A.C. 
Cl6 - 19 (4) Total Amount of Drug at 5 cm 
C20 - 23 ( 4) Total Fluid Intake at 5 cm or End of Trial 
C24 - 26 (3) Total Fluid Output at 5 cm or End of Trial 
C27 ( 1) Success or Not 1. Yes 
2. No 
3 . Dubious 
C28 (1) Pattern Description (of contractions) 
0 = Labour Did Not Occur 
1 = Unknown 
2 = Very Regular 
3 = Regular 
4 = Irregular 
5 = Very Irregular 
C29 (1) Fetal Heart Rate 1. Benign Change 
2. Abnormal Change 
3. No Change 
Side Effects 
C30 (1) Hypertonus 1. Yes 2 • No 
C31 (1) Diarrhoea 1. Yes 2. No 
C32 ( 1) Nausea 1. Yes 2. No 
C33 (1) Vomiting 1. Yes 2. No 
C34 ( 1) Phlebitis 1. Yes 2 • No 
C35 (1) Other 1. Yes 2. No 
Sedation in Total Amounts 000 if not Given (Except Nepresol) 
C36 - 38 ( 3) Pethidine mg 
C39 - 41 (3) Aterax mg 
C42 - 43 ( 2) Sparine mg 
C47 ( 1) Nepresol 1 • Yes 2. No 
C48 
C49 - 51 
C52 
C53 - 54 
C55 - 57 
C58 - 59 
C60 - 63 
C64 - 67 
C68 - 69 
C70 - 71 
(1) Sedation When Given 1. 0 - 5.59 hours 
2. 6 - 12 hours 
3. Both 
4. Neither 
(3) Interval From Onset of Infusion -
Spontaneous Rupture of the Membranes 
in Minutes 
(000 if ARM) 
(1) Operative Delivery 
1. Spontaneous Vaginal 
2. Forceps/Vacuum 
3. Caesarian Section 
(2) Apgar at 1 Minute 
(3) Haemoglobin Post-delivery 
(2) Urea Post-delivery 
(4) Fetal Weight gms 
(4) Placental Weight gms 
(2) Crown - Heel Length ems 
(2) Head Circumference ems 
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PENI NSULA MATERNI TY HOSPITA L 
NI\ME:., • . •• • ,., .. .. . ... ........ , . •• • AGE : • . . .• RAC E: ... FOLDER NO .: •••• , • , , , •• 
.Qfil: •.•••..•••.. • . 
DIAGNOS IS: DRUG: 
TIMf: 







URINE : I ---
Vol, ±r-~ -Osm. 
Na 













THE USE OF PROSTAGLANDIN E · TN THE MANAGEMENT OF - --------------2 
TNTRA-UTERTNE DEATH 
INTRODUCTION 
The term Intra-uterine Death (I.U.D.) embraces 
cases before the 28th week of pregnancy (missed abortion), 
and those occurring later which result in macerated 
stillbirth (Donald, 1969). 
The fetus is considered essential to the onset of 
labour (Liggins et al, 1972) and the onset of labour 
in association with intra-uterine fetal death therefore 
remains a paradox. As a result, the role of prosta-
glandins in intra-uterine death was studied in an attempt 
to provide a solution to the problem of management of 
this condition. 
At present prostaglandins are being administered 
by various routes to induce second trimester abortion 
(Badraoui et al, 1973) - intravenously, intra-amniotically, 
extra-amniotically and intra-vaginally (Embrey et al, 
1972; Hillier & Embrey, 1972; Hale et al, 1973). 
We have investigated the use of prostaglandin E
2 
(PGE2 ) administered by the extra-amniotic route in 
patients with an intra-uterine death, in order to find a 
solution to the management of this problem. 
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PATIENTS AND METHODS 
Twenty six patients with an intra-uterine death, 
seen over a period of 3 months in Groote Schuur Hospital, 
were studied. 
The diagnosis was made by the following methods: 
(1) Clinically: By absence of fetal movements, absence 
of fetal heart on auscultation and reduction of uterine 
growth over a period. 
(2) Ultrasonically: By progressive reduction in the fetal 
biparietal diameter, flattening and overlapping of the 
skull bones with duplication of the skull bone echoes, 
and reduction in the uterine volume. 
(3) Radiologically: The radiological signs include over-
lapping of the skull bones (Spalding's sign), acute 
angulation of the fetal spine, and gas shadows in the 
large vessels and lungs. 
The use of ultrasonics over X-ray was favoured 
as a method of confirmation of the diagnosis for the 
following reasons: 
(a) The diagnosis is made earlier, approximately 2 weeks 
before radiological signs appear. 
(b) It is possible to exclude a normal pregnancy without 
risk to the live fetus (Kukard, In press). 
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Immediately prior to induction venous blood was with-
drawn from the patient for the estimation of plasma oestra-
diol, plasma progesterone and human placental lactogen. 
These investigations were repeated every 2 hours until 
delivery and then 24 hours later. 
METHOD OF PLASMA PROGESTERONE ESTIMATION 
Plasma progesterone was measured by a modification 
of the competitive protein binding mechanism of Johansson 
(1970). 
METHOD OF PLASMA OESTRADIOL MEASUREMENT 
Plasma oestradiol was measured by radio-immunoassay. 
A modification of Abrahams' procedure (1969) without 
preliminary separation of oestrogens by chromatography 
was employed. The antibody used was highly specific for 
oestradiol. 
METHOD OF HUMAN PLACENTAL LACTOGEN MEASUREMENT 
Human Placental Lactogen (H.P.L.) was measured 
according to the method of Letchworth et al (1971) using 
the H.P.L. radio-immunoassay kit obtained from the Radio-
Chemical Centre, Amersharn. 
The method of administration of the extra-amniotic 
prostaglandin was as described by Embrey et al (1972). 
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A No. 16 Foley's catheter containing a measured, pre-filled 
Ampicillin and saline solution was introduced through the 
cervix to lie just within the internal os, between the 
membranes and the uterine wall. The balloon of the 
catheter was filled with 30 ml of the same solution. 
A prostaglandin E
2 
solution was prepared by adding 
5 mg of prostaglandin E2 into 20 ml of sterile water for 
injection. This gives a solution strength of 250 µg/ml. 
The solution in the Foley's catheter was then displaced 
by an equal volume of the prostaglandin E
2 
solution. An 
initial test dose of 125 µg of prostaglandin E
2 was then 
injected and after 10 minutes a further 250 µg was injected. 
Thereafter 375 µg (1~ ml) of the prostaglandin E2 
solution was injected every 2 hours until delivery. 
The patients were examined vaginally every 2 hours 
to assess changes in the cervix. 
Aseptic precautions were strictly observed throughout 
the procedure. As an additional precaution against 
infection the patients received systemic Ampicillin. 
RESULTS 
All patients were successfully delivered vaginally. 
The clinical details of the patients are shown in 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The mean age of the patients was 31 years. The average 
gestational maturity of the pregnancy at the time of 
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induction was 31.3 weeks with a mean fundal height of 27.5 weeks. 
The mean duration between the occurrence of the intra-
uterine death and induction, where known, was 14.4 days. 
The mean amount of PGE 2 administered to the
 patients 
was 1.125 µg (1.8 mg). 
Patients experienced their first contractions between 
4 and 20 minutes following the intra-uterine extra-amniotic 
administration of the PGE 2 solution, with a mean of 8.8 
minutes. No patients experienced contractions prior to 
the actual administration of the prostaglandin solution. 
The contractions became frequent and painful early on 
during the induction with a sustained increase of basal tone 
as measured by external tocography using a Hewlett Packard 
cardiograph, number 8020A. The induction-delivery 
interval ranged from 2 to 16 hours with a mean of 8.6 hours. 
SIDE EFFECTS 
The absence of side effects was noteworthy. Patient 
No. 2 complained of nausea early on in her labour and 
Case No. 26 vomited twice. Cases 3 and 10 had 2 and 1 
diarrhoeal stools respectively. 
COMPLICATIONS 
Delivery of fetus and placenta was complete, except 
in Case No. 17, which was complicated by a retained 
placenta and a post-partum haemorrhage. The placenta 
had to be removed manually and the patient received a 
3 pint blood transfusion. Bleeding was otherwise well 
within normal limits in all the patients. 
No cases of sepsis occurred. 
DISCUSSION 
In earlier years the accepted management of the dead 
fetus in utero was one of watchful expectancy (Gochberg 
& Reid, 1966), and this is often the case today. 
This conservative attitude, besides causing 
inconvenience and grief to the patient (Pritchard, 1959; 
Wolff et al, 1970), may lead to disturbance of the 
coagulation mechanism (Hodgkinson et al, 1954; Barry et 
al, 1955; Pritchard & Ratnoff, 1955; Quinn & Harper, 1955). 
The reason for this conservative attitude is that 
in most patients with an intra-uterine death labour ensues 
within 2 or 3 weeks (Tricomi & Kohl, 1957), and the risk 
of the retained fetus becoming infected following surgical 
induction was too great to attempt it. 
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Ursell (1972), however, compared cases of intra-
uterine death treated with an oxytocin infusion only, 
with cases in whom amniotomy was used in addition to 
oxytocin. He found no difference between the 2 groups 
and a slightly increased incidence of puerperal pyrexia 
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in the group where amniotomy was performed. One patient 
on a high dose oxytocin drip, which failed to induce labour, 
had a convulsive episode, probably due to wate~ retention. 
This anti-diuretic action of oxytocin is well known 
/ 
(Roberts et al, 1970). Liggins (1962) also described a 
case of severe water retention using oxytocin intravenously 
in the induction of a 30 week amenorrhoea missed abortion. 
Using oxytocin alone the induction failed in 43% of cases. 
This high failure rate and a prolonged induction-delivery 
interval are the main criticisms of the use of oxytocin 
to induce patients with an intra-uterine death. 
Lower Uterine Segment Caesarian Section or hysterotomy 
are unacceptable methods of treatment (Filshie, 1971), 
except under special circumstances. 
The instillation of hypertonic saline has potentially 
dangerous side effects, including maternal death (Wagatsuma, 
1965; Cameron & Dayan, 1966). This technique is also 
associated with a long latent interval before the onset 
of labour (Csapo et al, 1963). Hypertonic glucose has 
an increased incidence of infection and is also associated 
with a long latent interval (Wood et al, 1962). 
In Intra-uterine Death there is only 1 specific 
study (Filshie, 1971). The other reports are sporadic 
and incidental (Beazley et al, 1970; Karim et al, 1970; 
Beazley & Gillespie, 1971). Filshie (1971) reported 7 
cases of intra-uterine death successfully treated with 
an intravenous infusion of PGE2 • 
He obtained a mean infusion delivery interval of 
8 hours 30 minutes, which is identical to that obtained 
in this series. The gestational maturity of the cases 
at the time of induction, however, was 35 weeks, compared 
to the mean of 31 weeks reported in this series. 
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He also noted the absence of side effects as reported 
in this series. 
Beazley et al (1970), in a paper on induction of 
labour with PGE 2 , induced 3 cases with an intra-uterine 
death between 29 and 33 weeks maturity using intravenous 
One patient required a repeat infusion. The 
induction-delivery interval ranged between 12 to 23 hours. 
Karim et al (1970) in a paper on induction of 
labour with PGE 2 included cases with an intra-uterine 
death between 35 and 42 weeks maturity. The induction-
delivery interval ranged from 5~ hours to 31 hours and 
1 patient required a repeat infusion. 
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Beazley & Gillespie (1971), in a double blind trial 
of PGE 2 and oxytocin in induction of labour, induced 
labour successfully in 5 out of 8 patients with fetal 
death in utero using PGE 2 • Three cases with an intra-
uterine death received oxytocin, and the induction failed 
in 1 of these. Their impression was, from this and 
their earlier study (Beazley et al, 1970), that PGE 2 is a 
more useful drug than oxytocin for the induction of labour 
in these cases. 
From the results described above the extra-amniotic 
route seems to offer advantages over all theother methods 
discussed. The minimal side effects obtained with this 
technique of administration is noteworthy, compared with 
the severe side effects of high dose intravenous infusions 
of primary prostaglandins for termination of mid-trimester 
pregnancies (Hillier & Embrey, 1972). 
Unfortunately the serial hormone and enzyme analyses 
were not available at the time of completion of this thesis. 
Table 2 below gives the results available. It shows the 
+ mean - S.E of plasma oestradiol and plasma progesterone 




































































































































































































































It is curious that despite the apparent progesterone 
block (Csapo, 1961) PGE 2 acted faster than the other 
methods reported above, and this provides further 
evidence that prostaglandins are involved in the onset 
of labour. 
It is felt that prostaglandins have an important 
and practical role in the management of the retained dead 
fetus. 
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